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of chemical carcinogenesis is becoming increasingly
important as a supplement to rodent studies.However,
much of the molecular biology of the carcinogenic
response is still unknown in the trout model.The ras
gene family has been implicated in the tumorigenesis of
both spontaneous and chemically-induced tumors in
mammals.This study is the first to characterize a ras
proto-oncogene in rainbow trout.To accomplish this,
the ras gene sequence was amplified in vitro by using
polymerase chain reaction (PCR).
Two synthetic and degenerative oligonucleotide
sequences based on a consensus mammal/goldfish ras
sequence were used as primers in the PCR procedure.
An 800 base pair (bp) sequence was amplified from trout
genomic DNA and hybridized with a human c-Ha-rassequence.The initial amplifications of trout liver
cDNA using the PCR procedure with the synthetic ras
primers resulted in a single product of approximately
216 bps.However, this amplified "trout"216 by
product was subsequently shown to be an artifact of
carryover from a human Ki-ras plasmid.Carryover is a
common problem found in many laboratories involved with
the PCR procedure, and extensive precautions were used
to eliminate the problem in our laboratories.
The 800 by PCR product was cloned and sequenced
using Taq polymerase.RT-8, a clone containing the 800
by insert, was shown to have 91% homology to the first
two exons of mammalian c-Ha-ras gene and lesser
homology to other ras genes.Amplification of trout
liver cDNA using specific primers based on the RT-8
sequence resulted in the amplification of sequences
identical to the sequence of the RT-8 insert without
an intron, as well as unique sequences, which may
represent additional trout ras genes.The PCR
procedure was modified to identify sequence information
immediately 3' of the known trout ras sequence.
Partial sequences of at least two different trout ras
genes are presented.With this new information,
analysis of DNA sequence information from chemically
initiated tumors may elucidate the role activation of
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INTRODUCTION
Cancer is not a single disease, but a collection
of diseases possibly with many different causes but
with a common basis:uncontrolled cell growth often
accompanied by loss of cell differentiation.Although
epigenetic factors leading to cancerous growth are
known (Reitz & Watanabe, 1983), genetic mechanisms
continue to be the primary focus of cancer studies.
Investigations ranging from whole animal studies to
alterations in the DNA are in progress to probe into
the cause, prevention and treatment of cancer.
The idea of a genetic mechanism for cancer is not
a recent development.Evidence supporting a genetic
basis for cancer include 1) familial clustering of many
forms of cancer indicating genetic predisposition
(Hansen & Cavenee, 1987); 2) specific chromosomal
abnormalities associated with particular cancers
(Sasaki, 1985; Klein, 1983; Baker et al., 1989); and
3) transfer of cell-free extracts from tumor cells into
receptive animals resulting in the formation of tumors
(Shih et al., 1979b).A proposal by Huebner and
Todaro (1969) suggested the possibility of cellular
genes in control of cellular differentiation and growth
in normal cells going awry in neoplastic cells.An
"oncogene" was later defined as being a eukaryotic gene2
which 1) encodes for a protein, 2)is preserved in
evolution and presumably fulfills an essential
physiological role in the normal cell, and 3) has the
potential to become a dominant oncogenic determinant
(Vogt et al., 1985).The first oncogene to be
isolated was thesrcgene found in the avian Rous
sarcoma virus (Rous, 1911).The first oncogene to be
implicated in human cancer was a member of the ras
family (reviewed in Levinson, 1986; Barbacid, 1987;
Lacal & Tronick, 1988; Santos et al., 1982).
The ras Oncogene
Members of the ras family were first identified as
the transforming genes of seven highly oncogenic
retroviruses.The first virus to be isolated was the
Harvey-Murine Sarcoma Virus (MSV; Harvey, 1964)
containing the v-Ha-ras oncogene.A second related ras
oncogene, known as v Ki ras, was found in an isolate of
the Kirsten-MSV (Kirsten & Mayer, 1987).Subsequently,
five different viral isolates have been reported, each
containing a form of the v-Ha-ras oncogene:BALB-MSV
(Peters et al., 1974), Rasheed-MSV (Rasheed et al.,
1978), AF-1 (Franz et al., 1985), and NS.C58 MSV-1 and
-2 (Fredrickson et al., 1987).The structure of the
viral ras genes and the analysis of deletion mutants of
Ha-MSV (Cichutek & Duesberg, 1986) showed that the ras
gene sequences were sufficient for transformation of
the recipient cells to the oncogenic phenotype.It was3
eventually shown that the retroviruses had captured
distantly related cellular sequences from their rodent
hosts (Ellis et al., 1981), and subsequently modified
the sequences to conform with the viral genomes.There
is no current evidence for any involvement of oncogenic
viruses carrying ras genes in human cancer.
Two cellular homologs of both Ha-ras and Ki-ras
were identified in mammalian genomes using the viral
sequences as probes (Chang et al., 1982b).In each
case, one locus contained a pseudogene derived from a
processed mRNA (Miyoshi et al., 1984; Ruta et al.,
1986a; McGrath et al., 1983).The pseudogenes (known
as c-Ha-ras-2 and c-Ki-ras-1 respectively) lacked any
intervening sequences and differed from the viral and
active cellular sequences by base substitutions, inser-
tions, and deletions resulting in several premature
terminations in-frame.In humans, the locus for
c-Ha-ras-2 is located on the X chromosome at Xpter-q28
(O'Brien et al., 1983), and c-Ki-ras-1 is located at
6p12-p23 (McBride et al., 1983; O'Brien et al.,
1983).Active genes corresponding to Ha-ras and Ki-ras
were located at the other loci identified with the
respective viral probes.In the case of the Ha-ras
proto-oncogene (known as c-Ha-ras-1), the gene is
composed of 567 base pairs (bps) separated into four
translated exons preceded by an untranslated exon, and
is located on human chromosome 11 at p15.1-p15.54
(McBride et al., 1982; O'Brien et al., 1983).The
entire gene spans less than six kilobases (Kbs) in
length in all mammalian genomes (Capon et al., 1983).
No traditional promoter sequences, such as TATA or
CAAT signals, have been found for c-Ha-ras but the 5'
promoter region has a high GC content (Honkawa et al.,
1987) and several GC boxes similar to the human EGF-
receptor promoter (Ishii et al., 1985).The DNA
binding protein Spl binds to the promoter region
(Ishii et al., 1986), and the promoter region is also
responsive to the phorbol ester TPA and to serum
factors (Imler et al., 1988).Two separate enhancer
regions containing positive and negative elements have
been identified in the first intron of the human
c-Ha-ras gene (Honkawa et al., 1987).An additional
enhancer region located in the fourth intron was
identified by a point mutation responsible for
increased expression and transforming activity in the
cloned T24 colon cancer oncogene (Cohen & Levinson,
1988).Also identified in the 3' end of the cloned T24
oncogene is a variable tandem repeat (VTR) sequence
which has been shown to have transcriptional enhancer
activity and to be highly polymorphic in the human
population (Spandidos & Holmes, 1987).The
polyadenylation signal of the human c-Ha-ras gene has
been identified 407 bps downstream of the fourthexon,
resulting in mRNA transcripts of 1.1-1.3 Kbs in length5
(Gibbs et al., 1984; Goldfarb et al., 1982; Reddy,
1983; Ruta et al., 1986b).
The Ki-ras proto-oncogene (named c-Ki-ras-2) is
also divided into four translated exons with an
untranslated exon upstream of the first translated
exon. However, there are two alternative fourth exons
(identified as 4a and 4b) which encode for proteins of
188 and 189 amino acids respectively (McGrath et al.,
1983).Two mRNA transcripts (5.2 and 2 Kbs) have been
identified in humans as Ki-ras specific (Ruta et
al., 1986b).The intervening sequences of the
mammalian c-Ki-ras-2 gene are also much larger than
c-Ha-ras-1 with the total gene spanning up to 50 Kbs.
Possibly due to its large genomic size, the
transcriptional regulatory elements of c-Ki-ras-2 have
not been described in as much detail as the regulatory
elements of the human c-Ha-ras gene.The human
c-Ki-ras-2 gene has been mapped to 12p12.1-pter
(McBride et al., 1983; O'Brien et al., 1983).
A third closely related member of the ras family
was identified in a NIH 3T3 mouse cell line transfec-
tion assay (Shimizu et al., 1983).N-ras was
originally isolated from a human neuroblastoma cell
line, and to date no naturally occurring retrovirus has
been isolated containing a viral homolog of N-ras.The
structure of N-ras is comparable to the other ras
proto-oncogenes, except that two additional6
untranslated exons exist downstream of the fourth exon,
and several RNA splicing options have been observed.
Three mRNA transcripts of 5.0, 2.4, and 1.3 Kbs have
been identified as N-ras specific (Ruta et al.,
1986b).The promoter region of N-ras is similar to
that of c-Ha-ras-1 with no obvious TATA or CAAT box but
with a GGGCGG sequence upstream of the first exon.The
human N-ras gene is located at 1p22-p32 (McBride et
al., 1983; Davis et al., 1983; DeMartinville et al.,
1983).
The cellular counterparts of the viral ras onco-
genes are evolutionarily well-conserved and present in
low copy numbers in the various genomes.In all
vertebrates, the three classical ras genes are 100%
homologous for the first eighty amino acid residues
with greater than 80% homology at the DNA sequence
level.Amino acid residues 80 through 165 have less
homology, but are still very similar between the
different ras gene products.The carboxy terminus has
the greatest divergence among the ras genes, with the
only constant being a cysteine residue followed by two
hydrophobic residues at the extreme carboxy end.The
exon sequences of several ras genes in various
vertebrates are shown in Table 1.
Distantly related genes have been identified with
30-65% DNA sequence homology to the three primary ras
genes, leading to the classification of ras as aTable 1.Several vertebrate ras sequences.
EXON 1
10 20 30 40 50 60
Human H1ATGACGGAATATAAGCTGGTGGTGGTGGGCGCCGGCGGTGTGGGCAAGAGTGCGCTGACC
Rat H2 A C T TA- C A C
Chicken H3 C -GC A ATA C -G C -TT----G
Human K4 T A - -TATATT-CA CT - - - -G
Rat K5 T -G A - -T AT -ATT- CA CT - - - -G
Mouse K6 T -G AT TATT- CA CCT G
Goldfish7 A TCAGTA- C TCC
Human N8 T -GCA T -AAT TG- ACA A
Mouse N9 T -GCA T -AAT TG- ACC G
70 80 90 100 110
Human HATCCAGCTGATCCAGAACCATTTTGTGGACGAATACGACCCCACTATAGAG
Rat H GTT
Chicken H - -A CT T -TG A
Human K - -A AT T T- TAA
Rat K - -A AT TC TTTTG
Mouse K - -A AT TC TG TG
Goldfish A -C C AC
Human N A C A -T TT C
Mouse N A C T TT CTable 1.Several vertebrate ras sequences (cont.).
EXON 2
120 130 140 150 160 170 180
GATTCCTACCGGAAGCAGGTGGTCATTGATGGGGAGACGTGCCTGTTGGACATCCTGGATACCGCCGGC Human H
Rat H -C A A TT AC T-A--C--A--A--T
Chicken A-A AC C A C -TTC GGG
Human K A A A A A- AC -TCTTCCAAT
Rat K - -C A A -AAA A-ACTCTTCCAAT
Mouse K - -C A A -AA A A- AC -TCTTCCA-A T
Goldfish- -C A G T T- CT -AT
Human N TA-AA -A TA T- AC -TT A A -TA
Mouse N T A A G T C C A CA -TA
190 200 210 220 230 240
Human HCAGGAGGAGTACAGCGCCATGCGGGACCAGTACATGCGCACCGGGGAGGGCTTCCTGTGT
Rat H A -A TT A C - --
Chicken T A A A -G A A C
Human K - -A TA-A A G -T T -T - --
Rat K - -A T -AA A A -T T -T - --
Mouse K - -A T -AA A A -T T -T - --
Goldfish A T A G -AA C - --
Human N A -A T A A A A G -ACA C - --
Mouse N - -A T A A A G -ACAG C---
250 260 270 280 290
Human HGTGTTTGCCATCAACAACACCAAGTCTTTTGAGGACATCCACCAGTACAGG
Rat H - -A C A T
Chicken - -C T C
Human K -A AT -TTAA A- TT TTA
Rat K -A AT -TTAA A- TT T - -T --
Mouse K - -A AT -TTAA A- TT T - -T --
Goldfish- -C -C T C T C A
Human N - -A T -T G A C TTATC
Mouse N - -A T -T GAA CA- TTATCTable 1.Several vertebrate ras sequences (cont.).
EXON 3
Human H
Rat H
Chicken
Human K
Mouse K
Goldfish
Human N
Mouse N
Human H
Rat H
Chicken
Human K
Mouse K
Goldfish
Human N
Mouse N
Human H
Rat H
Chicken
Human K
Mouse K
Goldfish
Human N
Mouse N
300 310 320 330 340 350
GAGCAGATCAAACGGGTGAAGGACTCGGATGACGTGCCCATGGTGCTGGTGGGGAACAAG
G ATA T A
GA A A TC -C A-AT AAT TA -TA -T A-AT AAA TA -T T
A A A G C
TGA AA TA -T
ATGT ATTT -TC
C
ATA
CAA -ATA
C A
C T - --
A A
A -C
360 370 380 390 400 410
TGTGACCTGGCTGCACGCACTGTGGAATCTCGGCAGGCTCAGGACCTCGCCCGAAGCTAC
T TG C TTC T
T - - -C -A GA GA -C AG G G - -T - --
TT--C--T-T--A--A--A--CA-AAAA T-A--AA----T--T
TTC- T TA-AAA -CA GAAA GT-A--AA-G--T---
TTC-GT C G CA CAAG TT-AAG
TT--C-AA--A-G--A--T--TA-AAAA--A--C--C--A--G---AAG--T---
TC-AA--A-G--A--T--CA-AAAG--A--C--C--A--G---AAG--T---
420 430 440 450
GGCATCCCCTACATCGAGACCTCGGCCAAGACCCGGCAG TAAA
- -G A AG A-A A
-A--T--T-TTTAAAA AA -A - --
--G--T--G-TC--T A -A AA -A - --
TT--A A -A GA A
-- G-- T-- A- T- -T - -A A A A
A-- T-- A -T-T A A
%.0Table 1.Several vertebrate ras sequences (cont.)
EXON 4
Human H
Rat H
Chicken
Human Ka
Mouse Ka
Human Kb
Mouse Kb
Goldfish
Human N
Mouse N
Human H
Rat H
Chicken
Human Ka
Mouse Ka
Human Kb
Mouse Kb
Goldfish
Human N
Mouse N
460 470 480 490 500 510
GGAGTGGAGGATGCCTTCTACACGTTGGTGCGTGAGATCCGGCAGCACAAGCTGCGGAAG
- T
-CCA
A
A
G-TTT
- TTC
A-A A
T- TA
-T
AC A -A T T -A A
TCA G T TA
T- T -TA A A A- -AT - -- GAT -- AAA -A
TT -TA A A A TGAT--AAA--A
TAA -TAA- TAA ATAGAAAAG-T-
TA A -CA A- TAA ATAGAAAAG-T-
T -TTC----A--G--A---A----AT--CG----A-A--A
T - -T AC----AA-A--A--A--C---T--CGAA--AAA--A
T AC AA G ACTCGAT--AAA---
520 530 540 550 560 570
CTGAACCCTCCTGATGAGAGTGGCCCCGGCTGCATGAGCTGCAAGTGTGTGCTCTCCTGA
G -TT
A - -A T AT -ACA-A--G---
A-C-G-AAAGAA--AA---C-CCTGGCT-TGTG-AA-TTAAA--A--CA-TA-AATG-A-
A-C-G-AAAGAA--AA---C-CCTGGCT-TGTG-AA-TTAAA--A--C--TA-AATG-A-
AGC--AGA-GG-A-AA---AGAAAAAGAAG-CA-A-...ACA AA TATG-A-
AGC--AGA-GGGA-GA---AGAAGAAGAAG-CA-G-...ACA-G----ACAG-TATG-G-
--C-GTAAAGAA--A----CAACA-AAT--AT--A-CTT (End of insert)
--C---AGCAG TG GACT AGT- TG-A TGCCA G-GATG-A-
--C---AGCAG---C--TG-CACT-AA--T--T---G-G-CGCCC GATG-AG
Reddy, 1983; 2Ruta et al., 1986b; 3Westaway et al., 1986; 4Chang et
al., 1982 5Tahira et al., 1986 6George et al., 1985 7Nemoto et al., 1986
8Taparowsky et al., 1983 9Guerrero et al., 198511
superfamily of related genes.Members of the ras
superfamily have been identified in mammals, birds,
insects, fish, mollusks, plants, fungi, slime molds,
and yeast.Probing a human genomic library at low
stringency with v-Ha-ras identified R-ras, a gene that
encodes for a 218 amino acid protein (Lowe et al.,
1987).The homology between R-ras and the other
mammalian ras genes is 55% at the amino acid level, and
a mouse R-ras gene has also been identified.Screening
of a simian B-cell cDNA library with a synthetic
oligonucleotide probe based on a highly conserved
region of the ras genes resulted in the isolation of
the ral gene.The ral gene encodes for a 206 amino
acid protein with 50% homology to theras gene product
(Chardin & Tavitian, 1987).
Among the lower eukaryotes with ras-related genes
are Drosophila (Dras-1, Dras-2, and Dras-3),
Dictyostelium (Ddras), Saccharomyces cerevisiae
(RAS-1, RAS-2, YPT),and Schizosaccharomyces pombe
(SPRAS).The homology of D-ras-/ to c-Ha-ras-1 is
greater than 90% for the first 120 amino acids, whereas
D-ras-2 and D-ras-3 have less than 60% homology to
c-Ha-ras-1 (Neuman-Silberberg et al., 1984; Schejter &
Shilo, 1985).Dd-ras of Dictyostelium has an overall
homology of 65% (Pawson et al., 1985; Reymond et al.,
1984).The ras gene products from the yeast species
all are larger than the vertebrate forms and range in12
homology from 38% (YPT) to 65% (RAs-1, RAS-2, and
sPRAs) for the first 165 amino acid residues (Gallwitz
et al., 1983; DeFeo-Jones et al., 1983; Powers et al.,
1984; Haubruck et al., 1987; Fukui & Kaziro, 1985).
Homology to the yeast YPT gene identified a family
of genes in a rat brain cDNA library known as rab.The
similarity between YPT and the rab isolates is 37-75%,
but the homology between rab and mammalian ras falls to
approximately 30%. The rho gene has 30-40% homology to
the ras genes and was first isolated from the marine
snail Aplysia (Madaule & Axel, 1985).The rho gene has
since been found in human, rat, yeast and Drosophila
genomes.Homology to Drosophila D-ras-3 gene has
identified another related gene family in human cDNA
libraries known as raplA, rap1B, and rap2 with 50%
homology to the classical ras genes (Pizon et al.,
1988).The ras superfamily has also been extended to a
prokaryotic gene.The era gene, isolated from
Escherichia soli, has amino acid homology greater than
40% to the yeast RAS-1 and RAS-2 genes (Ahnn et al.,
1986).
Expression of the ras Genes
Members of the ras gene family are expressed in
nearly every cell at some level.Different mammalian
organs have substantially different levels of
expression of Ha -ras, Ki-ras, and N-ras (Leon et al.,
1987).In mice, Ha-ras is strongly expressed in brain,13
muscle, and skin with lower expression in liver and
ovary.The highest expression of Ki-ras was found in
the gut, lung, and thymus with lower expression found
in liver, muscle, skin and ovary.Expression of N-ras
is high in thymus and testis and lower in liver and
kidney.Expression of the different ras genes also
varied during development.Expression of Ha-ras was
constant throughout fetal development, whereas
expression of Ki-ras and N-ras peaked at 10-13 days of
gestation and declined substantially by the end of
pregnancy.Differential expression of the ras genes
suggest varying roles for each gene in either
proliferation or differentiation.Differential ras
expression has also been observed in rat organs (Tanaka
et al., 1986; 1987).
Activation of the ras Gene
The identification of ras as the first oncogene
isolated in a human neoplasm led to the discovery of a
single nucleotide substitution resulting in the
activation of a proto-oncogene (Parada et al., 1982;
Santos et al., 1982; Capon et al., 1983a; 1983b;
Barnes, 1986; Tabin et al., 1982).In this case,
activation is defined as a genetic alteration which
causes misdirection of a normal cellular gene into
producing an oncogenic phenotype.Activating mutations
have been limited to codons 12 (Capon et al., 1983a;
1983b; Reddy et al., 1982; Tabin et al., 1982;14
Taparowsky et al., 1982; Fasano et al., 1983), 13 (Bos
et al., 1985; Hirai et al., 1987), 59 (Dhar et al.,
1982; Tsuchida et al., 1982), and 61 (Taparowsky et
al., 1983; Yamamoto & Perucho, 1984; Brown et al.,
1984; Bos et al., 1984; Pelling et al., 1988) in
naturally occurring tumors.Table 2 lists many human
cancers in which the activation of a ras gene has been
implicated in carcinogenesis, and Table 3 lists animal
carcinogenesis studies showing ras activation.
Additionally, in vitro mutagenesis of codons 63 (Fasano
et al., 1984), 116 (Walter et al., 1986), and 119
(Sigal et al., 1986b) have been shown to activate the
ras proto-oncogenes.The consequences of these
mutations will be discussed later.
Although the majority of ras activations has been
the result of a single base substitution without any
further modification, overexpression or larger muta-
tions such as deletions or gene amplification have also
resulted in neoplastic transformation in vitro
(McCoy et al., 1983).Insertion of retroviral
regulatory elements near normal ras genes or the
inclusion of multiple copies of normalras genes caused
malignant transformation in NIH 3T3 cells and resulted
in 30-100 fold increase inras expression (Chang et
al., 1982a; Pulciani et al., 1985; Cohen et al., 1987).
Elevated expression of ras genes has often been shown
in a variety of tumors when compared to the expressionTable 2.Incidence of ras activation in human cancer.1
Malignancy Cell GeneMutation Reference
Source? Type Site
Bladder C:EJ,T24 H 12 Capon et al., 1983a;
Parada et al., 1982; Pulciani
et al., 1982; Reddy et al.,
1982; Santos et al., 1982;
C:WEB H Marshall, 1985
C:A1698 K 12 Barbacid, 1985
C:A1163 K 12 Valenzuela & Groffen, 1986
B (2/38) H 61 Fujita et al., 1985
B (1/38) H 12 Fujita et al., 1985
B (2/28) H Malone et al., 1985
B (1/15) H Fujita et al., 1987
B (4/24) H VisVanathan et al., 1988
B N 61 Kuzumaki et al., 1989
Breast C:HS578T H 12 Kraus et al., 1984
C:MDA-MB231 K 13 Kozma et al., 1987; Rochlitz et
al., 1989
C:PE600I K 12 Rochlitz et al., 1989
B (0/16) Kraus et al., 1984
B (1/40) K 13 Rochlitz et al., 1989
B (2/24) H 12 Spandidos, 1987
Cervix B (0/30) Bos, 1988
B (7/76) Riou et al., 1988Table 2.Incidence of ras activation in human cancer (cont.)
Malignancy Cell GeneMutation Reference
Source? Type Site
Colon
Esophagus
Fibrosarcoma
Gall Bladder
C:SW480
C:A2233
C:Duke-2
C:SK-00-1
C:7060
C:CC20
B
B
B (9/27)
B (1/27)
B (1/27)
B (26/66)
B (26/40)
B (6/9)
B (65/172)
B (5/75)
B (0/9)
B (0/25)
C:HT1080
C:A1604
C:A1609
B (0/5)
K 12 Bos et al., 1986; Capon et
al., 1983b; McCoy et al., 1984
K Pulciani et al., 1982
K McCoy et al., 1983
K 12 Winter et al., 1985
N 61 Yuasa et al., 1986b
H 12 Greenhalgh & Kinsella, 1985
K 12 Yuasa et al., 1986a
N Murray et al., 1983
K 12 Bos et al., 1987a
K 61 Bos et al., 1987a
N 12 Bos et al., 1987a
K 12 Forrester et al., 1987
K 12 Burmer & Loeb, 1989
K 12 Burmer et al., 1989
K Vogelstein et al., 1988
K Farr et al., 1988a
Feinberg et al., 1983
N
K
K
Hollstein et al., 1988
61 Brown et al., 1984
Barbacid, 1985
Pulciani et al., 1982
Almoguera et al., 1988Table 2.Incidence of rasactivation in human cancer (cont.)
Malignancy Cell
Source?
Gene
Type
Mutation
Site
Reference
GlioblastomaC:Hu70 N Gerosa et al., 1989
C:Hu104 N Gerosa et al., 1989
C:Hu112 N Gerosa et al., 1989
C:Hu195 N Gerosa et al., 1989
C:Hu197 N Gerosa et al., 1989
B (0/30) Bos, 1988
Kidney B (1/16) H 12 Fujita et al., 1988a
B (1/16) H 61 Fujita et al., 1988a
Liver C:7402 N Gu et al., 1986
C:Hep G2 N Barbacid, 1985
B (3/10) N Gu et al., 1986
B N Barbacid, 1985
B N Yuan et al., 1988
B H Zhang et al., 1987
Lung C:HS242 H 61 Yuasa et al., 1983
C:SK-LU-1 K 12 Winter et al., 1985
C:Lx-1 K Der et al., 1982
C:A2182 K 12 Santos et al., 1984
C:A427 K 12 Valenzuela & Groffen, 1986
C:A549 K 12 Valenzuela & Groffen, 1986
C:PR310 K 61 Yamamoto & Perucho, 1984;
Yamamoto et al., 1985
C:PR371 K 12 Nakano et al., 1984; Yamamoto
et al., 1985Table 2.Incidence of ras activation in human cancer (cont.)
Reference Malignancy Cell GeneMutation
Source? Type Site
Lung C:SW1271 N 61
(cont.) C:Lu-65 K 12
C:Calul K 12
C:LC-12-JCK K
C:QG56 K 61
B K
B K 12
B (15/45) K 12
B (0/10)
Melanoma C:SK-MEL146 H
C:SK-MEL93 N
C:SK-MEL119 N
C:SK-MEL147 N
C:SK-MELSWIFTN 61
B H 61
B (3/8) H
B (1/10) H 61
B (1/13) N 61
B (7/37) N
NeuroblastomaC:SK-N-SH N 61
B (1/15) N 13
B (1/15) N 61
B (0/25)
Yuasa et al., 1984
Taya et al., 1984
Capon et al., 1983b; Shimizu et
al., 1983
Fukui et al., 1985
Kagimoto et al., 1985
Pulciani et al., 1982
Santos et al., 1984
Rodenhuis et al., 1988
Feinberg et al., 1983
Albinoetal.,1984
Albinoetal.,1984
Albinoetal.,1984
Albinoetal.,1984
Paduaetal.,1985
Sekiyaetal.,1984
Ananthaswamy et al.,1988
Leon et al., 1988
Raybaud et al., 1988
van't Veer et al., 1989
Taparowsky et al., 1983
Ireland, 1989
Ireland, 1989
Ballas et al., 1988Table 2.Incidence of ras activation in human cancer (cont.)
Reference Malignancy Cell GeneMutation
Source? Type Site
Ovary B (3/37) K
Pancreas C:A1165 K 12
C:Pancl K 12
C:T3M-4 K 61
B K 12
B K
B (21/22) K 12
B (28/30) K 12
B (47/63) K 12
Rhabdomyo- C:RD301 N 61
sarcoma B K
Skin B H 61
(keratoacanthoma)
Stomach B K 12
B N 61
B (0/7)
B (0/26)
Terato-
carcinoma
C:PA1 N 12
van't Veer et al., 1988
Valenzuela & Groffen, 1986
Malone et al., 1985
Hirai et al., 1985a
Yamada et al., 1986
Pulciani et al., 1982
Almoguera et al., 1988
Smit et al., 1988
Grunewald et al., 1989
Chardin et al., 1985
Pulciani et al., 1982
Leon et al., 1988
Bos et al., 1984
O'Hara. et al., 1986
Fujita et al., 1985
Sakato et al., 1986
Tainsky et al., 1984Table 2.Incidence of rasactivation in human cancer (cont.)
Malignancy Cell
Source?
Gene
Type
Mutation
Site
Reference
Thyroid B (2/5) H 61 Lemoine et al., 1988
FollicularB (2/5) K 12 Lemoine et al., 1988
B (2/5) N 61 Lemoine et al., 1988
Papillary B (1/10) K 13 Lemoine et al., 1988
B (1/10) N 61 Lemoine et al., 1988
B (0/20) Fusco et al., 1987
Acute C:Rc-2a N 12 Janssen et al., 1987
Myeloid C:KG-1 N 12 Janssen et al., 1987
Leukemia C:THP-1 N 12 Janssen et al., 1987
C:HL60 N 61 Bos et al., 1987b
C:PAC N Murray et al., 1983
C:31-26-146 N Eva et al., 1983
B N 12 Gambke et al., 1985
B (3/6) N Needleman et al., 1986
B (4/45) N 61 Bos et al., 1987b
B (6/45) N 13 Bos et al., 1985
B (2/45) K 12 Bos et al., 1987b
B (13/52) N 12 Farr et al., 1988
B (1/52) N 13 Farr et al., 1988
B (7/10) N Hirai et al., 1987
B (1/9) H 12 Janssen et al., 1987
B (1/9) N 12 Janssen et al., 1987
B (3/9) N 61 Janssen et al., 1987
B (5/18) N Senn et al., 1988
B (7/26) N Yunis et al., 1988
B (15/57) N Bartram et al., 1989
B (1/9) Pedersen-Bjergaard etal.,1988Table 2.Incidence of ras activation in human cancer (cont.)
Reference Malignancy Cell
Source?
Gene
Type
Mutation
Site
Chronic C:IM9 N
Myeloid B (0/25)
Leukemia B (0/26)
B (3/12) H 12
B (1/12) N 12
B (1/8) N
Juvenile B K
Myelo- B (1/19) N 12
dysplasticB (3/8) N 13
syndrome B (20/50) N/K
B (11/27) N
B (3/34) K
Myeloproli-
ferative
B (1/15) N 12
Syndrome
Acute C:RPMI N
Lymphoid C:CCRF-CEM K
Leukemia C:T-ALL1 N
C:p-12 N
C:MOLT4 N 12
B (2/19) N 12
B (0/14)
B (6/33)
Eva et al., 1983
Bos, 1988
Janssen et al., 1987
Liu et al., 1988
Liu et al., 1988
Hirai et al., 1985b
Janssen et al., 1985
Janssen et al., 1987
Hiraietal.,1987
Paduaetal.,1988
Yunisetal.,1988
Lyonsetal.,1988
Janssen et al., 1987
Souyri&Fleissner,1983
Eva etal., 1983
Souyri&Fleissner,1983
Souyri&Fleissner,1983
Eva et al., 1983
Rodenhuis et al., 1986
Senn et al., 1988
Neri et al., 1988Table 2.Incidence of ras activation in humancancer (cont.)
Malignancy Cell GeneMutation Reference
Source? Type Site
Burkitt C:AW Ramos N Murray et al., 1983
Hodgkin B (2/3) N Sklar & Kitchingman, 1985
Hairy cell B (0/6) Neri et al., 1988
Idiopathic B (2/9) N Buschle et al., 1988
Myelofibrosis
1Updated from data presented in Bos, 1988; 1989.
2C: cell line; B biopsy (incidence/total)Table 3.Incidence of ras in animal models of carcinogenesis.
SpeciesOrgan Chemical
Mouse
GeneMutationIncidenceReference
CD-1 Breastdibenz(c,h)-
acridine
BALB/cFibro- 3-methyl-
sarcomas cholanthrene
B6C3/F1 Liver spontaneous
A/J
A/J
Liver 4-(N-methyl-N-
nitrosamino)-1-
(3-pyridy1)-1-
butanone
H
K
N
H
H
Liver nitroso- K
dimethylamine
B6C3/F1 Liver nitroso- H
diethylamine
B6C3/F1 Liver 1-hydroxy-2',3'-H
dihydroesyragole K
B6C3 /Fl Liver N-hydroxy-2- H
acetlaminoflurene
61 1/1
4/14
11/23
15/27
0/5
2/11
12 1/8
61 14/33 Stowers et al. 1988
Bizub et al., 1986
Borrello et al.,1988
Reynolds et al.,1986
Reynolds et al.,1987
Belinsky et al.,1989
Belinsky et al.,1989
61 10/11Wiseman et al., 1986
1/11
61 7/7 Wiseman et al., 1986Table 3.Incidence of ras in animal models of carcinogenesis(cont.).
SpeciesOrgan Chemical GeneMutationIncidenceReference
Mouse (cont.)
B6C3 /FlLiver vinyl carbamate H 61 7/7 Wiseman et al., 1986
B6C3/F1Liver furan H 61 5/29 Reynolds et al., 1987
H 117 4/29
K 2/29
B6C3 /FlLiver furfural H 13 2/16 Reynolds et al., 1987
H 61 6/16
H 117 1/16
K 1/16
A/J Lung spontaneous K 12 6/10 Belinsky et al., 1989
K 61 3/10
Lung tetranitromethane K 12 Guerrero & Pellicer,
1987
A/J Lung 4-(N-methyl-N- K 12 8/10 Belinsky et al., 1989
nitrosamino)-1-K 61 2/10
(3-pyridy1)-1-
butanone
A/J Lung nitroso- K 12 7/10 Belinsky et al., 1989
dimethylamine K 61 3/10Table 3.Incidence of ras in animal models of carcinogenesis (cont.).
SpeciesOrgan Chemical GeneMutationIncidenceReference
Mouse (cont.)
SENCARSkin spontaneous
Skin B-propiolactone
CD-1 Skin 7,12-dimethyl-
benzanthracene
CD-1 Skin benzo(a)pyrene
CD-1 Skin dibenz(c,h)-
acridine
Thymicnitrosomethyl-
lymphoma urea
Rat
F344 BladderN-butyl-N-
(4-hydroxybuty1)- 1988b
nitrosamine
H
H
61
61
7/9
1/6
Pelling et al., 1988
Hochwalt et al., 1988
H 61 3/4 Bizub et al., 1986
H Balmain & Pragnell, 1983
0/3 Bizub et al., 1986
H 61 4/5 Bizub et al., 1986
N 61 Guerrero et al., 1985
H 61 1/9 Fujita et al.,Table 3.Incidence of ras in animal models of carcinogenesis(cont.).
Species Organ Chemical GeneMutationIncidenceReference
Rat (cont.)
Breast spontaneous 0/26 Zarbl et al., 1985
Breastnitrosomethyl- H 12 48/58 Zarbl et al., 1985
urea H 12 61/71 Sukumar et al., 1983;
Barbacid et al., 1986
Breast7,12-dimethyl- H 61 3/14 Zarbl et al., 1985
benzanthracene H 61 5/26 Barbacid et al., 1986
F344 Fibro-
sarcoma
1,8-dinitro-
pyrene
K 12 1/7 Tahira et al., 1986
F344/NLiver spontaneous 0/29 Reynolds et al., 1986
Fischer Liver aflatoxin Bl K 2/11 McMahon et al., 1986
K 12 3/4 Sinha et al., 1988
N 1/4
F344 Liver nitrosodiethyl-
nitrosamine
0/28 Stowers et al., 198827
in adjacent normal tissues (Spandidos & Kerr, 1984;
Spandidos & Agnantis, 1984; Spandidos et al., 1985;
Williams et al., 1985; Viola et al., 1985; Agnantis et
al., 1986; Agnantis et al., 1988; Clair et al., 1987).
Overexpression of the nonactivated c-Ha-ras gene,
however, did not fully transform in Rat-1 cells, nor
did the overexpression of the nonactivated form
suppress the transformation by the activated c-Ha-ras
gene (Ricketss & Levinson, 1988).Truncation of the 5'
noncoding exon of a nonmutated Ha-ras gene has resulted
in cellular transformation in some cases (Cichutek &
Duesberg, 1986) but not in all cases (Tabin & Weinberg,
1985).The degree of DNA methylation, often involved
in the regulation of specific gene expression,may play
a role in controllingrasgene expression.In vitro
methylation of an activated human Ha-rasgene decreased
its transforming activity in the NIH 3T3 transfection
assay approximately 80% (Borrello et al., 1987).The
transforming activity was recovered aftera 24 hour
incubation in the presence of the DNA-demethylating
agent 5-azacytidine.Hypomethylation of both c-Ha-ras
and c-Ki-ras was achieved in rats by dietary methyl
deficiency; however, all DNA samples showed
hypomethylation regardless of the tissuesource
(normal, preneoplastic or neoplastic)or exposure to
the carcinogen diethylnitrosamine (Bhave etal., 1988).The activation of ras genes in tumor tissue but
not in normal surrounding tissue (Kraus et al., 1984;
Santos et al., 1984; Burmer et al., 1989) has
strengthened the conclusion that ras is involved in
human carcinogenesis.Precisely whenras involvement
28
occurs may differ depending on the circumstances.In
many cases, the activation of ras is seen as an early
event in the carcinogenic process.Activated ras genes
have been identified in preneoplastic lesions in the
mouse skin carcinoma model (Balmain et al., 1984) and
are predominant in rat mammary carcinoma initiated with
a single dose of nitrosomethylurea (Sukumar et al.,
1983;Zarbl et al., 1985).In human cancer, activated
ras genes are found in benign and malignant regions of
a human colon carcinoma (Bos et al., 1987a), and
precede aneuploidy in human colon carcinoma (Burmer et
al., 1989).An activated ras gene is
sufficient to cause transformation of established
preneoplastic cell lines such as the NIH 3T3mouse cell
line, but generally requires the presence of a second
activated oncogene (Land et al., 1983) or
proliferating agents (Imler et al., 1988; Marczynska et
al., 1988;Pelling et al., 1988) for transformation of
primary rodent cells.Without any secondary support,
an activated ras gene cannot sustain total neoplastic
transformation (Leon et al., 1988).A second activated
oncogene is not required, however, for the transforma-29
tion of normal embryonic cells (Spandidos & Wilkie,
1984).Activation of ras is not always associated with
initiation or the early stages of carcinogenesis.One
example of late activation in an animal model showed
ras activation only in the later stages of mouse
lymphoma (Vousden & Marshall, 1984).Studies of human
myeloid leukemia (Janssen et al., 1987; Yunis et al.,
1988) and melanoma (Albino et al., 1984; van't Veer et
al., 1989) have also shown ras activation occurring in
both early and late stages of neoplasia.Tumor
promotion or tumor progression may be facilitated by
the activation of ras in proliferating cells which have
been initiated by other activated oncogenes (Albino
al., 1984).
The ras Gene Product
et
The ras genes in vertebrates code for a phospho-
protein of 21,000 Daltons knownas p21 (Shih et al.,
1986).A precurser protein of 23,000 Daltons (p23) has
been identified in the biosynthesis of p21 (Shih, et
al., 1982), and post-translational modification of the
phosphoprotein involves the covalent binding of
palmitic acid to the cysteine residuenear the carboxy
terminal (Buss & Sefton, 1986; Fujiyama & Tamanoi,
1986; Chen et al., 1985; Magee et al., 1987).p21
has been localized to the interior side of the cellular
plasma membrane (Shih et al., 1979a; Shih et al.,
1979c; Willingham et al., 1980) and the acylated30
cysteine residue is required for membrane attachment
(Willumsen et al., 1984a; 1984b) and transforming
activity (Willumsen et al., 1984a), but acylation is
not required for normal RAS function in S. cerevisiae.
Specific monoclonal antibodies capable of recognizing
the different ras p21 proteins have been produced
(Wong et al., 1986; Yoshida et al., 1988).
Microinjection of the ras p21 protein or its antibody
has been shown to affect cellular morphology (Bar-Sagi
& Feramisco, 1986; Stacey & Kung, 1984), division
(Baltus et al., 1988;Birchmeier et al., Wigler,
1985; Sadler et al., 1986), or differentiation (Bar-
Sagi & Feramisco, 1985; Haga et al., 1986; Satoh et
al., 1987).
The conservation of the ras genes across such
diverse species indicated a fundamental role in the
cell life cycle.A common characteristic of all ras
gene products was found to be the capacity to bind
guanine nucleotides (Scolnick et al., 1979; Shih et
al., 1979a; Trahey et al., 1987).This strong
similarity to a class of proteins known as G proteins
indicated a possible function for theras proto-
oncogene in the nontransformed cell (Hanley & Jackson,
1987; Halliday, 1984; Hurley et al., 1984; Lochrie et
al., 1985).G proteins function as signal transducers
across the cell membrane in a variety of cells (Pall,
1985; Gilman, 1987).Stimulus of a receptor on the31
cell surface requires the signal to be transmitted
across the membrane to the cytoplasm and possibly to
the nucleus for cellular response (Barnes, 1986).The
G protein is coupled to membrane receptors of
extracellular signals and to effectors of intracellular
second messenger systems (Sullivan et al., 1987;
Chabre, 1987).The G protein is activated by
replacement of a guanine diphosphate (GDP) molecule
with a guanine triphosphate (GTP) molecule.Inactiva-
tion occurs when the GTP molecule is hydrolyzed to GDP
by an intrinsic GTPase activity of the G protein.Some
cellular processes regulated by G proteins include
activation and inhibition of adenylyl cyclase (Robishaw
et al., 1986; Masters et al., 1988; Mattera et al.,
1989), stimulation of retinal cyclic GMP phospho-
diesterase (Yatsunami & Khorana, 1985; Deterre et al.,
1988; Brann, 1988), stimulation of phosphoinositide
hydrolysis (Uhing et al., 1986; Cockcroft & Gowperts,
1985; Cockcroft, 1987), and regulation of ion channels
(Scott & Dolphin, 1987;Caffrey et al., 1987; Cerbai
et al., 1988; Van Dongen et al., 1988; Yatani et al.,
1988; Mattera et al., 1989).
Therasgene product of the nonactivated proto-
oncogene also has an intrinsic GTPase activity, and an
associated protein, GTPase-activating protein (GAP),
acts as an effector molecule (Adari et al., 1988;32
Trahey & McCormick, 1987; Trahey et al., 1988;
Hoshino et al., 1988; McCormick, 1989).GAP, a series
of monomeric proteins of 100-125 kDaltons, has the
ability to stimulate GTP hydrolysis by the normal p21
molecule 200-fold, yet has no effect on the oncogenic
variants.The GTPase activity is generally absent or
greatly reduced in the activated gene product (Gibbs et
al., 1984; Finkel et al., 1984; Sweet et al., 1984;
Manne et al., 1985).However, an activated p21 has
been shown to retain a strong GTPase activity and yet
still be able to transform NIH 3T3 cells (Papageorge
et al., 1982;Lacal et al., 1986), leading to the
conclusion that a function other than GTP hydrolysis is
also involved in neoplastic transformation.The p21
molecule is also capable of autophosphorylation,
especially evident in viral forms (Shih et al., 1979a).
The site of autophosphorylation is the threonine
residue at position 59, and in contrast with the GTPase
activity, autophosphorylation activity is increased in
the oncogenic variants (Gibbs et al., 1984).
The three-dimensional structure of p21 has
recently been characterized (de Vos et al., 1988;
Schlichting et al., 1989).The structure contains one
0-sheet containing six strands, four a-helices, and
nine connecting loops.The GDP or GTP molecule sits in
a pocket formed by four of the nine loops (L1, L2, L7,
and L9).The catalytic site for the hydrolysis of GTP33
is most likely loop Ll, with loop L2 the probable
recognition site for the GAP molecule.Activating
mutations of the ras genes affect guanine nucleotide
binding capacity of the gene product (Feig et al.,
1986; Der et al., 1986; Lacal & Aaronson, 1986; Lacal
et al., 1986; Clanton et al., 1986; Sigal et al.,
1986a; 1986b; Clanton et al., 1987).Mutants at
residue 12 or 13 (located in loop Ll) cause the loop to
become enlarged and would explain the reduction in
GTPase activity (Tong et al., 1989).Mutants at
residue 61 alter the long loop L4 which spans the
molecule, again enlarging the pocket for guanine
nucleotide binding (Pincus et al., 1987).Another
consequence of the reported base substitutions is a
reduction in the guanine-binding strength, resulting in
an enhancement of the exchange of GTP for GDP.The
phosphorylation of threonine-59 stiffens the conforma-
tion of p21 around the guanine nucleotide molecule.
The ultimate outcome in every case is an increase in
the concentration of GTP-bound p21 molecules
(Srivastava et al., 1985), prolonging the activated
signal.
The precise function (or functions) of theras
genes in the cell is not yet known, although several
possibilities are under investigation.In yeast, RAS
proteins have been shown to control growth arrest by
stimulating adenylyl cyclase activity (Toda et al.,34
1985).Other cellular functions in yeast that require
RAS activity include spore viability (Tatchell et al.,
1984) and endocytosis (Mayorga et al., 1989).
Nonmutated RAS genes require the CDC25 protein for
optimum activity; mutant RAS genes have full activity
without the CDC25 protein (Broek et al., 1985; 1987;
Robinson et al., 1987).The CDC25 protein also
controls other functions of the RAS genes in addition
to the stimulation of adenylyl cyclase activity (Wigler
et al., 1988).
Both mammalian and yeast ras gene products work in
heterologous systems, indicating the conservation of
ras gene functions over evolutionarily distant species
(DeFeo-Jones, 1985; Papageorge et al., 1986; Temeles et
al., 1985; Kataoka et al., 1985; Lowe et al., 1988).
However, in contrast with its action in yeast, p21 does
not appear to be part of the adenylyl cyclase pathway
in mammalian or Xenopus cells (Beckner et al.,1985;
Birchmeier et al., 1985) with the exception of two
studies involving rat cell lines.Increased adenylyl
cyclase activity was observed in rat thyroid epithelial
cells transformed with viralras genes (Spina et al.,
1987), and rat kidney cells infected witha temperature
sensitive viral Ki-ras had a stimulation of adenylyl
cyclase as the cells entered early G1 phase (Frankset
al., 1985).However, in a vast majority of the
studies, a separate second messenger signallingsystem35
is the probable target of p21 function.Oncogenic
forms of p21 stimulate inositol phospholipid breakdown
and this pathway may be the target signalling system
(Chicirugi et al., 1985; Fleischman et al., 1986;
Preiss et al., 1986; Lacal et al., 1987; Lacal et al.,
1987; Wolfman & Macara, 1987).Phosphatidylinositol
4,5-bisphosphate (PIP2) hydrolysis is stimulated by
neurotransmitters, hormones, serum and growth factors
(Berridge & Irvine, 1984; Joseph, 1984; Cockcroft,
1987; Hill et al., 1988; Coughlin et al., 1989).PIP2
hydrolysis is catalyzed by polyphosphoinositide
phosphodiesterase (a form of phospholipase C) to
generate two intracellular signals: diacylglycerol
(DAG) and inositol 1,4,5-trisphosphate (IP3).As
intracellular regulators of growth, DAG activates
protein kinase C and 1P3 stimulates Ca2+ release from
storage vesicles in the cytosol (Gill et al., 1986).
One G protein (Gp) specific for the PIP2 pathway
has been identified that is distinct from, yet hasmany
similarities to, p21 (Cockcroft & Gowperts, 1985;
Smith et al., 1986).DAG levels, but not
IP3 levels, were elevated in ras- transformed
fibroblasts (Wolfman & Macara, 1987) and ina
temperature-sensitive Ki-ras transformed cell line
incubated at permissive temperatures (Preiss et al.,
1986).These studies have strengthened the connection
between phospholipase C andras p21 (Yu et al., 1988;36
Melin et al., 1986).Seuwen et al., however, have
shown that phospholipase C is not the mediator of ras-
transformed Chinese hamster lung fibroblasts (1988),
and Benjamin et al. have shown decreased phospholipase
C activity in ras-transformed NIH 3T3 cells (1987a;
1987b).Other second messenger systems are being
investigated.One candidate for investigation is a
direct interaction with protein kinase C (Ballester et
al., 1987; Jeng et al., 1987).
The coupling of p21 to a transmembrane receptor is
necessary for activity in the normal cell cycle.
Several hormones and other molecules have been linked
to receptor:ras p21 complexes, including platelet
derived growth factor (PDGF)(Coughlin et al., 1989),
epidermal growth factor (Kamata & Feramisco, 1987;
Parries et al., 1987), bombesin (Wakelam et al., 1986),
transferrin (Finkel & Cooper, 1984), and insulin
(Deshpande & Kung, 1987; Korn et al., 1987; O'Brien et
al., 1983; Kamata et al., 1987; Sacks et al., 1989).
In addition to controlling cell proliferation,ras
has also been implicated in cell differentiation.
Microinjection of normal and activated p21 into PC12
neural cells induced differentiation (Satoh et al.,
1987).Transfection of the viral Ha-ras oncogene into
human medullary thyroid carcinoma cells induced
differentiation into functioning endocrine cells.In
contrast, oncogenic p21 molecules, but not normal37
forms, inhibit differentiation of mouse muscle cell
line C2 into skeletal myoblast cells (Olson et al.,
1987) .
Trout Model of Carcinogenesis
Fish models are used in a wide variety of
scientific disciplines, including genetics, develop-
mental biology, neurobiology, and aquatic toxicology
(reviewed in Powers, 1989).Many species can be
utilized in both laboratory and field studies.The
genetic background is well established for many fish
species, including several species that have been
manipulated to produce homozygous strains, either by
inbreeding or constructed in the laboratory by physical
means (Streisinger et al., 1981; Thorgaard et al.,
1985) .
Fish are used not only as representative species
of an aquatic environment but also as important
alternative vertebrate models for comparative biology.
There are obvious differences which preclude complete
comparisons between mammalian and fish physiology;for
example, the absence of lung or mammary tissue in the
fish species.However, basic embryology and
biochemistry are a few of the manyareas where
knowledge can be increased by comparative studies
across phyla.Depending on the requirements of the
study, an ideal model can be found amongst thelarge
number of diverse fish species.Most fish are very38
prolific, producing hundreds of externally fertilized
eggs, allowing ample opportunity to study embryonic
development.Smaller aquarium fish have the advantages
of short generation time and require small rearing
areas, but are often too small to adequately obtain
isolated tissue samples in quantities sufficient for
enzymology or metabolism studies.Many fish species,
such as rainbow trout (onco.rhymohusmykiss,formerly
classified as Sa/mogairdnern, grow much larger, and
can be used more effectively in studies requiring large
amounts of tissue, but have longer generation times and
require larger areas for rearing.Other advantages and
limitations of fish models in general and rainbow trout
in particular, have been presented by Bailey et al.
(1984) .
Fish species have been used in carcinogenesis
studies for over twenty-five years.A direct link
between hepatic carcinoma in hatchery rainbow trout and
aflatoxin B1 contamination of the feed given to the
trout established trout as a valuable and sensitive
model for carcinogenicity testing (Wales & Sinnhuber,
1966; Ayres et al., 1971).Although several other
species have been used in carcinogenesis studies
(Toledo et al., 1987; Stanton, 1965; Khudoley, 1972;
Sato et al., 1973; Kyona, 1978; Woodhead, Setlow, and
Pond, 1982; Schultz and Schultz, 1982; Barkenow et
al., 1982; Kimura et al., 1983; Smith et al., 1979;39
Grizzle et al., 1981; Falkmer et al., 1977), the
species used most extensively for this purpose has been
rainbow trout.Rainbow trout are sensitive to a wide
range of carcinogens (Meyers & Hendricks, 1982), can be
exposed by several different routes (Hendricks et al.,
1984; Bailey et al., 1987), and isolated tissue can
easily be obtained for further biochemical and
molecular studies (Williams & Buhler, 1983; Bailey et
al., 1982; Loveland et al., 1984).
Although many aspects of carcinogenesis have been
thoroughly investigated in the trout model, very little
is known about the molecular biology of trout
carcinogenesis.The only trout oncogene that has been
previously characterized is the myc oncogene (Van
Beneden et al., 1986).A form of the src gene
identified in a hybrid of swordtails (Xiphophorus) is
responsible for melanoma in that species.Other fish
species in which ras has been reportedly identifiedare
goldfish (Nemoto et al., 1986; 1987), tomcod (Wirgin et
al., 1989; Wirgin et al., 1989) and winter flounder
(McMahon, unpuplished data).This study will
characterize a ras gene isolated from rainbow trout.
In Vitro Gene Amplification
A recent development in the field of molecular
biology is a powerful tool known as polymerase chain
reaction (PCR).This procedure allows the selective in
vitro amplification of a particular sequence out of a40
complex genome without cloning into a vector system.A
schematic of the PCR procedure is illustrated in
Figure 1.Basically, the technique repeatedly mimics
the DNA synthesis procedure during a cell cycle:
separating the double strands of the target DNA,
annealing primer sequences for initiation of DNA
synthesis, and extension by a DNA polymerase to copy
the target DNA.By selecting primer sequences specific
for a particular gene of interest and repeating the
cycling 20-40 times, the gene (or a manageable portion
of the gene) is amplified a million-fold.The original
description of the PCR procedure used the heat-labile
Klenow fragment of the E. coli DNA polymerase I enzyme
(Saiki et al., 1985; 1986), and this required the
replenishment of the enzyme after each denaturation
step.Substitution of this heat-labile enzyme with the
heat-stable Taq DNA polymerase (isolated from the
bacterium Thermus aquaticus) greatly simplified the
procedure and permitted the possible automation of the
PCR process (Saiki et al., 1988).PCR has been used
in a wide variety of studies, including the analysis of
ras activation in cancer (McMahon et al., 1987; Farr et
al., 1988b; Hollstein et al., 1988; Almoguera et
al.,1988; Rodenhuis et al., 1988; Stevens et al., 1988;
van't Veer et al., 1988; Burmer et al., 1989).Original DNA
PCR primer
New DNA
/
I
/ \
I
I
1
1/
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I
* repeat for 25-40 cycles
I
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Figure 1.The polymerase chain reaction procedure.42
Although no exact sequence information has been
available for any trout ras gene, the highly conserved
nature of ras genes between diverse species can be
exploited in an attempt to locate the homologous
gene(s) in trout.Specifically, the selection of
primers derived from conserved regions of a consensus
of the vertebrate ras genes would hopefully allow the
in vitro amplification of one or more trout ras genes
that can be further analyzed by several traditional
methods.This structural information is essential for
future studies on the role of ras genes in neoplasia in
trout and other fish species.43
MATERIALS AND METHODS
General methods used are described further in
Davis et al., 1986.Unless otherwise specified,
chemicals were obtained from Sigma Chemical Co.(St.
Louis, MO).
DNA Isolation
Trout tissue samples were immediately frozen in
liquid nitrogen and pulverized in a mortar with a
pestle.The powder was suspended in 10 volumes RSB
buffer (10 mM Tris, pH 7.4; 10 mM sodium chloride
(NaC1); 25 mM EDTA).Sodium dodecyl sulfate was added
to equal 1% final volume, and proteinase K was added at
a concentration of 1 mg/ml.Each suspension was
incubated at 37°C for 4-8 hours until the sample became
uniformly viscous.Each sample was extracted with
Tris-saturated phenol (Boehringer Mannheim Biochem-
icals, Indianapolis, IN):chloroform (International
Biotechnologies, Inc., New Haven. CT):isoamyl alcohol
(25:24:1), and the top aqueous layer transferred toa
new tube without disturbing the interface.Each
aqueous phase was extracted twice with chloroform:
isoamyl alcohol (24:1) and once with diethyl ether.
The DNA from each sample was precipitated with 2.5
volumes of cold 95% ethanol (Aldrich, Milwaukee, WI)
and wound onto a glass rod.After transferring to a
new tube, the DNA was air-dried.The DNA was44
resuspended in TE buffer (10 mM Tris, pH 7.4, 1 mM
EDTA) with 20 pg/m1 DNase-free RNase A.
Messenger RNA (mRNA) Isolation
Tissue samples were immediately frozen in liquid
nitrogen and pulverized in a mortar with a pestle.The
powder was suspended in RNAzol (Cinna/Biotecx,
Friendswood, TX) at a concentration of 100 mg
pulverized tissue/2 ml RNAzol.Chloroform (1/10
volume) was added to the RNAzol suspension and mixed
well.After incubation at 4°C for 15 minutes, the
suspension was centrifuged at 10,000 x g for 15 minutes
to separate the organic and aqueous phases.The top
aqueous layer was transferred to a new tube, and total
RNA was precipitated with 1 volume isopropanol at -20°C
for 45 minutes and centrifuged at 10,000 x g for 15
minutes.The RNA pellet was resuspended in 1 ml
sterile distilled water containing 40 units RNasin
RNase inhibitor (Promega Biotec, Madison, WI).
Messenger RNA (mRNA) was isolated by passage of total
RNA through an oligo(dT)-cellulose column using a
commercial mRNA isolation buffer set (5 Prime-3 Prime,
West Chester, PA).The total RNA sample was heated to
65°C for 5 minutes.One volume of 2x Loading buffer
provided in the isolation buffer set was added to the
sample and reheated to 65°C.The sample was cooled to
room temperature and applied to a prepared 4 ml
oligo(dT)-cellulose column.After repeated washing to45
remove unattached RNA, the poly(A)+ mRNA was eluted
with the provided elution buffer.Nucleic acid in
aliquots of the eluate was detected by mixing 2 yl of
each aliquot with 10 yl dilute ethidium bromide
solution (1 µg /ml), dotting the sample on cellophane
wrap placed on a UV transilluminator, and observing the
fluorescence.Fluorescence-positive aliquots were
combined, and the mRNA was precipitated with 1/10
volume 2 M ammonium acetate and 3 volumes of 95%
ethanol.The mRNA in ethanol was stored at -80°C until
needed.At that time, the precipitated mRNA was
centrifuged at 12,000 rpm, and the pellet vacuum dried.
After resuspension in sterile distilled water
containing RNasin RNase inhibitor, the mRNA was
quantified by measuring an aliquot for absorbance at a
wavelength of 260 nm (Concentration = 40 pg /mi x
dilution factor x A260).
cDNA Synthesis
cDNA was synthesized using a commercial cDNA
synthesis system (Bethesda Research Laboratories,
Gaithersburg, MD).First strand synthesis was executed
at 37°C for 1 hour using 10 yg mRNA, Moloney MuLV
reverse transcriptase and oligo(dT)15 primer.Ten pl
of the total 50 yl reaction was removed after first
strand synthesis for use directly in the polymerase
chain reaction (see below).Second strand synthesis
was executed on the remainder of the first strand46
reaction.Second strand synthesis buffer, E. coli
polymerase I, and RNase H were added, and each reaction
was incubated at 16°C for 2 hours.The completed cDNA
was phenol/chloroform extracted, followed by ethanol
precipitation.The precipitated cDNA was resuspended
in 100 pl TE.
Polymerase Chain Reaction
In vitro gene amplification was accomplished using
a modification of the polymerase chain reaction (PCR)
protocol (Saiki et al., 1988).One mg of genomic DNA
or 100 ng of cDNA (first strand or fully synthesized)
was included in 50 Al reactions containing 50 mM KC1,
10 mM Tris, pH 8.3, 1.5 mM MgC12, 200 mM of each dNTP,
0.01% gelatin ,2-3 units Taq polymerase (Beckman,
Inc. Fullerton, CA) and 60 pmoles of both a 5' and a 3'
primer.In reactions designed to amplify the 3' end of
cDNA, however, 90 pmoles of the poly(dT)24 were used as
the 3' primer to account for the large number of
poly(dA) tails.The selection of primers was dependent
on the region of ras to be amplified as illustrated in
Figures 2-4.The actual primer sequences are listed in
Table 4.Primers were synthesized at the Center for
Gene Research at Oregon State University.Forty cycles
of denaturing at 94°C for 0.5-1.0 minutes, primer
annealing at 35-50°C for 0.5-1.0 minutes, and primer
extension at 65-70°C for 2-6 minutes were executed for
each PCR.To enrich for the correct PCR productGenomic DNA
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Figure 2.PCR amplification of a portion of arasgene
from genomic DNA.Two primers (one corresponding to
the sense strand at the 5' end of the sequence to be
amplified and one corresponding to the complementary
strand at the 3' end of the sequence to be amplified)
are indicated by arrows.The resulting PCR product
after amplification is shown below the original DNA
target.Genomic DNA
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(see Table 4 for sequences)
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Figure 3.PCR amplification of a portion of aras
sequence from cDNA.The relative positions of
several primers are shown, and the resultant PCR
products are depicted in the bottom portion of the
illustration.The actual sequences of the primers
are listed in Table 4.Genomic DNA
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Figure 4.PCR amplification of the 3' portion of aras
sequence from cDNA.Amplification of the 3' end of
cDNA is accomplished using a 5' primer and
poly(dT)24.The resultant PCR products (all >500 bps
in length) are depicted in the bottom portion of the
illustration.50
Table 4.ras PCR primers. (5'-3')
ras01 ATG ACZ GAA TAT AAX CTV GTG
ratKras01 ATG ACT GAG TAT AAA CTT GT
rasc72 CAT GTA CTG GTC CCV CAT VGC
rasc79 XAG XAA GCC CTC YCC ZCT WC
RTrasH01 ATG ACV GAA TAT AAG CTV GTG G
RTrasHc81 ACA CAG AGG AAG CCC TCY CC
RTrasHl2gly GGG GGC AGG AGG TGT GGG CA
RTrasH31 GAA TAT GAC CCC ACC ATC GAG
RTrasH38 GAC TCG TAC AGG AAG CAG GTG G
poly (dT)24 TTT TTT TTT TTT TTT TTT TTT TTT
A:adenine, C:cytosine, G:guanosine, T:thymidine,V:G or T,
W:G or C, X:G or A, Y:C or T, Z:A, T,or G.
containing the 3' end of cDNA, two sequentialPCRs were
executed (Ohara et al., 1989).After an initial PCR
amplification of either 10 or 40 cycles containing
cDNA, a 5' primer, and the poly(dT)24 primer, the PCR
reaction mixture was washed and concentrated witha
Centricon-100 (Amicon, Danvers, MA) andan aliquot used
in a second PCR reaction containingan internal 5'
primer and poly(dT)24.The PCR products were examined
by electrophoresis on a 4-6% acrylamide gel,
transferred to a Zeta-Probe membrane (Bio-Rad
Laboratories, Richmond, CA), hybridized and probedto
identify ras-positive bands (see below).51
Asymmetric PCR for direct sequencing was
accomplished by limiting the amount of one of the two
primers to 0.6 pmoles/50 Al reaction, 1/100 the
concentration of the unlimited primer.The selection
of the primer to be limited was in the same orientation
as the sequencing primer.
Southern Transfer
A fraction (5-10 pl) of each PCR reaction was
mixed with 1 pl of bromophenol blue/xylene
cyanol/glycerol loading dye and loaded onto a vertical
4% acrylamide gel.Electrophoresis was accomplished at
15 v/cm for 40-60 minutes.The gel was stained with
ethidium bromide and photographed with UV transillumin-
ation.The DNA was transferred in 1 M NaCl, 0.5 M NaOH
to ZetaProbe membrane by capillary action for 16 hours.
The membrane was rinsed in 2x SSC (0.3 M NaCl, 0.03 Na3
citrate, pH 7.0) and baked for 2 hours at 80°C.
Genomic DNA was digested with various restriction
enzymes (Bethesda Research Laboratories; Boehringer
Mannheim Biochemicals; Pharmacia, Piscataway, NJ; New
England BioLabs, Beverly, MA) using the appropriate 10x
reaction buffer and 5 units of enzyme/mg DNA, and
incubating the reactions for 16 hours at the
appropriate temperature for the various enzymes.The
concentration of DNA in the reaction was approximately
25 mg/500 ml total volume.The digested DNA was
concentrated using Centricon-30 concentrators.One pl52
of loading dye was added to 10 pg of digested DNA, and
the sample was loaded into each well of a horizontal
0.8% agarose gel.Electrophoresis was carried out at 3
v/cm for 4-8 hours until the bromophenol blue dye
reached 1 cm from the end.The gel was stained with
ethidium bromide and photographed with UV
transillumination.The gel was soaked with slight
agitation for 15-20 minutes in 0.25 M HC1 at room
temperature to hydrolyze the DNA, and the DNA was
transferred in 0.4 M NaOH to ZetaProbe membrane
by capillary action for 16 hours.The
membrane was rinsed in 2x SSC and baked for 2 hours at
80°C.
Radioactive Labeling of Hybridization Probe
Random primer labeling of DNA probes was achieved
using a32P-dATP (3000 Ci/mmol, 10 pCi/p1; Du Pont NEN,
Boston, MA) and a commercial random labeling system
(Bethesda Research Laboratories).Twenty-five
ng of probe DNA was heat-denatured in a volume of 23 Al
and placed on ice.Addition of 2 yl each of 0.5 mM
dCTP, 0.5 mM dTTP, and 0.5 mM dGTP was followed by
addition of 15 Al random primers buffer mixture, 5 pl
a32P-dATP, and 1 Al Kienowenzyme.The mixture was
incubated at room temperature for 1-4 hours.The probe
was heat-denatured before being added to the hybridiza-
tion solution.53
Hybridization
The membrane was prehybridized for 1-6 hours in
hybridization buffer (50% formamide, 6x SSC, 100 µg /ml
chicken DNA, 250 pg/m1 yeast RNA, 0.5% Carnation non-
fat dry milk, 1% SDS) at 42°C.Radioactive probe (25-
100 ng) was added to the hybridization solution and
incubated 14-30 hours at 42°C.The membrane was
removed from the hybridization solution and washed with
2x SSC, 0.1% SDS at room temperature for 15 minutes,
followed by washes of increasing stringency (2x SSC to
0.1x SSC and 42°C to 55°C) until a majority of the
membrane had radioactivity levels near background.The
membrane was blotted dry and wrapped in cellophane
wrap.Autoradiography of the membrane was done with
enhancer screens at room temperature, with exposure
times of 2 hours to 3 days.
DNA Extraction from Acrylamide Gel Slices
DNA from PCR reactions was concentrated using
Centricon-30 filtration units, mixed with 1/10 volume
loading dye, and electrophoresed through a vertical 4%
acrylamide gel at 15 v/cm for 1.0-1.5 hrs.The gel was
lightly stained with ethidium bromide and photographed
with UV transillumination.A section of the gel
containing DNA of the desired size (determined by
position relative to size markers) was sliced out using
a new razor blade.The DNA was eluted from the gel
slice into 0.5-1.0 ml of 0.5 M ammonium acetate by54
overnight incubation at 37°C with shaking.The eluted
DNA was concentrated using Centricon-30 filtration
units and used for direct sequencing or for cloning.
Cloning
Digestion of pUC 10 vector was achieved with a 2
hour incubation at room temperature with the appro-
priate 10x reaction buffer and 5 units of Sma I
restriction enzyme /µg DNA at a DNA concentration of 1
Ag/20 pl total reaction volume.The reaction was heat-
inactivated at 60°C for 15 minutes.Insert DNA was
concentrated using Centricon-30 or Ultrafree MC
filtration unit (Millipore, San Francisco, CA) and
combined with vector DNA at a ratio of 100:1 to 250:1,
and the DNA was precipitated with 1/10 volume 6.5 M
ammonium acetate and 2.5 volumes 95% ethanol.After
vacuum drying, the precipitated DNA was resuspended in
10 Al lx ligase buffer containing 1 unit T4 ligase
(Bethesda Research Laboratories) and incubated at 10-
14°C for 16 hours.The ligation mixture was diluted
1:5 and 1 pl was used to transfect 25 Al of DH5a
competent cells (Bethesda Research Laboratories).The
transfected cells were plated onto LB agar plates
containing ampicillin (100 µg /ml) with 10 pl 10% 5-
bromo-4-chloro-3-indolyl-p-D-galactoside (Xgal;
Boehringer Mannheim Biochemicals) in dimethylformamide
and 10 pl isopropyl -19 -D- thiogalactopyranoside (IPTG;
Boehringer Mannheim Biochemicals).The plated cells55
were incubated at 37°C overnight.White colonies were
screened for DNA insert size by mini-preparation
analysis and for probing by slot blot hybridization.
Plasmid Mini-preparation
After regrowth on an ampicillin grid plate,
bacteria were resuspended in 0.5 ml glucose buffer (50
mM glucose, 25 mM Tris, pH 8.0, 10 mM EDTA) containing
1 mg/ml lysozyme and incubated at 25°C for 10 minutes.
Ten Al of 10% SDS was added to each sample and mixed
well.Fifty Al of 3 M potassium acetate (KAc)
solution, pH 4.8 was added to each sample, mixed well,
and incubated on ice for 30 minutes.The samples were
centrifuged at 15,000 rpm in a Hermle tabletop
microfuge for 30 minutes at 4°C.The supernatant was
poured into a new tube, and the tube filled with 95%
ethanol.The DNA was precipitated by incubation at-
20°C for 15 minutes, followed by centrifugation at
12,000 rpm for 15 minutes.The DNA pellet was vacuum
dried, followed by resuspension in 20 Al TE containing
RNase A.Ten yl of each sample was added to 1 yl
loading dye.The samples were electrophoresed through
a 1% agarose gel at 10 v/cm for 30-45 minutes.The gel
was stained with ethidium bromide and photographed with
UV transillumination.
Slot blot hybridization
One Al of loading dye was mixed with 10 Al of
plasmid mini-prep DNA, or alternatively withwhole56
cells resuspended in 10 Al TE buffer.Fifty pl of 0.5
M sodium hydroxide (NaOH) was added to each sample, and
the mixture loaded onto a moistened ZetaProbe membrane
mounted into a slot blot apparatus.After adsorption
of the samples, the membrane was baked at 80°C for 1
hour before hybridization as mentioned above.Larger
preparations of positive clones were made to obtain
sequence-quality plasmid DNA.
Small Volume Plasmid Preparation
Bacteria containing probe-positive plasmids were
inoculated into 5 ml LB broth containing 100µg /ml
ampicillin and incubated overnight at 37°C with
shaking.The cells were pelleted by centrifugation at
3,000 x g.The cells were resuspended in 225 Al
glucose buffer.Addition of 75 Al glucose buffer
containing 8 mg/ml lysozyme was followed by incubation
at 25°C for 5 minutes.Six hundred Al of 0.2 M NaOH,
1% SDS was added to each sample, mixed well, and
incubated on ice for 5 minutes.Four hundred fifty Al
of ice cold 3 M KAc, pH 4.8 was added to each sample.
After mixing well, the samples were centrifuged for 10
minutes at 12,000 x g at 4°C.The supernatant was
transferred to a new tube, avoiding all precipitate.
Isopropanol (750 Al) was added to each sample, and the
sample was mixed by vortexing.After incubation at
-20°C for 15 minutes, the plasmid DNA was precipitated
by centrifugation at 12,000 x g at 4°C.The DNA was57
resuspended in 200 Al TE containing RNase A (25 µg /ml),
and immediately phenol/chloroform extracted.The DNA
was reprecipitated with 1/10 volume 6.5 M ammonium
acetate and 3 volumes of 95% ethanol.The plasmid DNA
was resuspended in 25 pl TE.One Al of the plasmid DNA
sample was mixed with 1 pl loading dye and 5 pl TE, and
the sample was electrophoresed through a 1% agarose gel
at 10 v/cm for 30-45 minutes.The gel was stained with
ethidium bromide and photographed with UV
transillumination.
Large Volume Plasmid Preparation
Bacteria containing the desired plasmid were
incubated overnight at 37°C with shaking in LB broth
containing 100 µg /ml ampicillin.The cells were
pelleted by centrifugation at 3,000 x g for 5 minutes,
and the supernatant discarded.The cells were
resuspended in 2 ml glucose buffer, followed byan
addition of 0.5 ml glucose buffer containing 10 mg/ml
lysozyme and incubation at room temperature for 5
minutes.Five ml 0.2 M NaOH, 1% SDS was added, mixed
gently, and the suspension was incubated 10 minuteson
ice.Four ml of ice-cold 3M KAc, pH 4.8 was added and
mixed well, followed by an additional 10 minute
incubation on ice.The samples were centrifuged for 10
minutes at 12,000 x g at 4°C.The supernatant was
transferred to a new tube, avoiding all precipitate.
Isopropanol (5.5 ml) was added to each sample, and the58
sample was mixed by vortexing.After incubation at -
20 °C for 15 minutes, the plasmid DNA was precipitated
by centrifugation at 12,000 x g at 4°C.The DNA was
resuspended in 1 ml TE containing RNase A (25 pg/ml),
and immediately phenol/chloroform extracted.The DNA
was reprecipitated with 1/10 volume 6.5 M ammonium
acetate and 3 volumes of 95% ethanol.The plasmid DNA
was resuspended in 100 pl TE.One pi of the plasmid
DNA sample was mixed with 1 pl loading dye and 5 pl TE,
and the sample was electrophoresed through a 1% agarose
gel at 10 v/cm for 30-45 minutes.The gel was stained
with ethidium bromide and photographed with UV
transillumination.
Restriction Mapping of Recombinant Plasmids
Each clone of interest was digested with 12-20
different restriction enzymes, with digestion using 1
or a combination of 2 enzymes/reaction.An aliquot of
each reaction was electrophoresed through a 5%
acrylamide gel at 20 v/cm for 45-60 minutes.The
fragment sizes were estimated by comparison to marker
band fragments.
Sequencing
Direct-sequencing of PCR products was achieved
when a strong band was amplified during the asymmetric
amplification.End-labeled primer was made using-y-
32P-ATP (3000 Ci/mmol, 10pCi/p1) and polynucleotide
kinase at 37°C for 1 hour.Sequencing reactions were59
executed according to a modification of Taq -Track
sequencing system (Promega Biotec).Concentrated PCR products
were suspended in 25 pl of lx Taq sequencing buffer,
heat-denatured at 95°C for 5 minutes and immediately
placed on ice.Ten pmol of end-labeled primer and 4
units of Taq DNA polymerase were added to the denatured
DNA.Six yl of the reaction mix was added to 1 pl of
each deoxy-/dideoxy-nucleoside triphosphate (d/ddNTP)
in an appropriately labeled tube and incubated at 70°C
for 5 minutes.The sequencing reactions were stopped
by the addition of 3ill formaldehyde stop solution.
The DNA was denatured at 95°C for 5 minutes before
being loaded onto a 8 M urea, 5% acrylamide sequencing
gel.The samples were electrophoresed for 2-4 hours at
a constant power of 45 watts.After drying at 80°C on
a slab dryer for 1 hour, autoradiography was carried
out at room temperature with 2-10 hour exposure before
film development.
Sequencing of probe-positive clones was also
accomplished using a different modification of Taq-
Track system (Promega Biotec).Plasmid DNA (100-2000 ng) was
denatured in 0.4 M NaOH for 5 minutes at 25°C.M13/pUC
primer (2 pmol) was added, followed by the addition of
potassium acetate (3 M K, 5 M acetate, pH 4.8) toa
final concentration of 0.45 M.Three volumes of 95%
ethanol was added and the sample was centrifuged at
12,000 rpm for 30 minutes to precipitate the denatured60
DNA.After air drying, the samples were resuspended in
5 Al 5x Taq buffer, 2 pl extension mix, and 11 Al
sterile distilled water.Two pl of a32P-dATP (3000
Ci/pmol, 10 mM) was added, followed by 1.5 pl Taq DNA
polymerase (5 units/Al) and immediately incubated at
37°C for 3-10 minutes.One Al of each d/ddNTP solution
was added to the appropriately labeled tube.Six pl of
the reaction mix was added to each d/ddNTP and
incubated at 70°C for 5 minutes.The sequencing
reactions were stopped by the addition of 3 pl
formaldehyde stop solution.The DNA was denatured at
95°C for 5 minutes before being loaded onto a 8 M urea,
5% acrylamide sequencing gel.The samples were
electrophoresed for 2-4 hours at a constant power of 45
watts.After drying at 80°C on a slab dryer for 1
hour, autoradiography was carried out at room
temperature with 2-10 hour exposure before film
development.61
RESULTS
PCR of Trout Genomic DNA
The use of degenerate primers in the PCR procedure
to identify possible ras-like sequences in trout
genomic DNA posed several problems.The annealing
temperature during the PCR reaction was lowered to
below 42°C to achieve visible products on ethidium
bromide gels.The lower annealing temperatures and the
degenerate primers resulted in nonspecific PCR
reactions, with many diffuse bands visible in each
reaction.Lowering the Mg2+ concentrations to a low
level (1.5 mM) improved the specificity of the
reactions to some extent (data not shown), but unique
bands were not observed with any reactions utilizing
degenerate primers to amplify ras sequences from
genomic DNA.Although ras-positive PCR products were
obtained from the positive control, mouse DNA, after
extension times of 2-3 minutes per cycle, the larger
ras-positive PCR products obtained from trout genomic
DNA required extension times of 4-5 minutes per cycle.
Figure 5 shows both an ethidium bromide-stained 1.2%
agarose gel and an autoradiograph of the transfer
membrane probed with a 1.0 Kb human c-Ha-ras probe.
The primers used for the reactions in this illustration
were ras01 and rasc72, and a similar ras-positive band
was obtained using the primers ras01 and rasc79.The
size of the ras-positive PCR product obtained froma)
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G - goldfish
TE - trout embryo
Mmouse
T - trout liver
Figure 5.PCR products of genomic DNA (a) An ethidium
bromide-stained 1.2% agarose gel displayingproducts
of a PCR amplification using primersras01 and rasc72,
and an extension time of 5 minutes.(b) An
autoradiograph of the transfer membrane probedwith a
1.0 Kb human c-Ha-ras probe.The arrow indicates
probe-positive bands of approximately 800 bps in
several lanes of products from PCR amplificationsof
trout genomic DNA.63
amplification of trout genomic DNA was calculated to be
approximately 800 bases in length, suggesting an intron
size of approximately 550 bases.This intron size is
different from any vertebrate ras gene previously
reported, indicating a sequence apparently unique to
trout.Direct sequencing of the ras-positive trout
genomic PCR product was not feasible due to the large
number of nonspecific PCR products in the reaction.
The DNA from reactions using the primers ras01 and
rasC72 was sized on a 4% acrylamide as mentioned in the
Materials and Methods section, and prepared for cloning
into the Sma I site of pUC 10 vector.
PCR of Trout Liver cDNA--Possible Carryover
Contamination
The PCR technique was used to amplify anyras
sequences expressed in normal trout liver, some of
which may have large introns to prohibit their
amplification from genomic DNA.As a positive control,
a linearized plasmid containing an activated human
Ki-ras cDNA was used as a companion reaction.Figure 6
shows ethidium bromide-stained 3% Nu-Sieve (FMC
BioProducts, Rockland, ME) agarose gel of both the
genomic and cDNA PCR products, and the accompanying
autoradiographs probed with either a 1.1 Kb human Ki-
ras cDNA probe or a 1.0 Kb human c-Ha-ras probe.Both
the trout genomic and liver cDNA PCR products contained
a 216 by band that probed positively with the Ki-ras64
Figure 6.Comparison of PCR products from genomic DNA
and cDNA.(a) An ethidium bromide-stained 3% Nu-Sieve
agarose gel of both the genomic and cDNA PCR
products.Lane 1 - isolated 800 by trout genomic PCR
product; Lane 2 - 216 by "trout" cDNA PCR product;
Lane 3 - 216 by human Ki-ras cDNA PCR product; Lane 4
- 500 by human Ha-ras genomic PCR product; Lane 5 -
trout genomic PCR products;Lane 6 - mouse genomic
PCR products.(b) Autoradiograph of the transfer
membrane probed witha 1.1 Kb human Ki-ras cDNA
probe.Arrow indicates the probe-positive 216 by
product in several lanes.(c) Autoradiograph of the
transfer membrane reprobed with a 1.0 Kb human
c-Ha-ras probe.Arrow indicates the probe-positive
800 by PCR product from amplifications of trout
genomic DNA.(Note: exposure time for the
autoradiograph of lanes 4-6 is 0.5 hr; the other
portion of the autoradiograph isan exposure of 2 hr)a)bps
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probe but not with the Ha-ras product (Figure 7)
revealed a sequence that was identical to the activated
human Ki-ras cDNA used as a positive control in
companion reactions.Since these species have been
separated by 400 million years of evolution, it is
unlikely that the ras gene sequences from the two
species would be identical.Therefore, the "trout"
sequence was believed to be in fact a human sequence
resulting from the PCR amplification of the positive
plasmid control contaminating the trout reactions.DNA
from several different trout individuals as well as a
control human placental DNA and rat liver DNA were
amplified using the original primers and conditions.
Sequencing of the human placental DNA PCR product
revealed the normal Ki-ras proto-oncogene sequence, but
the trout and rat PCR products again contained the
activated human Ki-ras sequence (data not shown).
Since the sequence of the rat Ki-ras is known to be
different from that of the human Ki-rasgene, carryover
contamination from the positive plasmid controlwas a
probable cause for the incorrect sequence information.
Restriction Mapping of Trout Genomic 800 by PCRInserts
of Recombinant Clones
Because of its unique intron size, the 800 by PCR
product would not be confused with anycarryover
product.To identify recombinant clones containing the
trout genomic PCR product, several white colonieswereCAG
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Figure 7.Sequencing gel autoradiograph showing
carryover contamination.The sequence is of the
216 by product from PCR amplificationof trout liver
cDNA.The sequence is identical to thatof the human
Ki-ras cDNA plasmid insert usedas a positive control
in the PCR reactions, and isbelieved to becarryover
contamination in the PCR amplificationof trout liver
cDNA.68
selected and sized by mini-preparation analysis for
inserts larger than 600 bps.Five separate clones
(Appendix Table I) were identified as possibly
containing the trout PCR product.Two of the 5 clones
were digested with 17 different enzymes, and Figure 8
shows an ethidium bromide-stained gel ofmany of the
digested fragments of clone RT-8.Very few restriction
sites were identified in the 800 by inserts; however,
an Xba I site was identified near the center of the
insert.Sizing and positioning the digested fragments
revealed a restriction map of RT-8 illustrated in
Figure 9.
Sequencing of Trout Genomic PCR Product Insertsof
Recombinant Clones
Partial sequencing of the 5 recombinant clones
containing the trout genomic 800 by PCR product
revealed each contained a similar sequence with
homology to mammalianrasgenes.Clone RT-8 was
identified as having a consensussequence of the 5.
Inserts in two clones (RT-6 and RT-8) were completely
sequenced and the sequence of the RT-8 insert is shown
in Figure 10.The insert contains the first exon and
131 bps of the second exon of arasgene that is
similar, but not identical, to vertebraterasgenes.
RT-8 Probing of Restriction Digested Trout GenomicDNA
Additional information on the structure ofthe
gene containing the 800 by sequence was obtained by69
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Figure 8.Restriction digests of RT-8.Ethidium
bromide-stained 6% acrylamide gel of cloneRT-8
digested with several restrictionenzymes.(Marker
sizes: 955 bps; 585 bps; 341 bps; 258bps; 141 bps;
105 bps; 78 bps; 75 bps)70
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Figure 9.Restriction map of the RT-8 insert.EXON 1 ATG ACG GAA TAT AAG CTT GTG GTG GTG GGG GCA GGA GGT GTG GGC AAG AGC GCG CTC
ACC ATC CAG CTC ATT CAG AAC CAC TTT GTG GAT GAA TAT GAC CCC ACC ATC GAG
INTRON GTAATAAGTAGTTTCAGTACACCCTTGTCTCTTACTTCAGCAAGGCATGCCTGGGAATCGGGAGACAAAAATCTT
TTAGAAATAAAGTTGTGTAAACAGGTTTCGATCATTTCTGATCATTTTCTGTTATTTGAATGCATGAATATTATA
ATATCATAAACATGGTGTCTTTCAGTCAGTTTAATTTTGTTGGTTGATGAAAGATTACTATGTGATTAAATGCTT
TAGTAGTTTCACATGTCAGATATTATTACTCAATTATACTTTCTGAAAGCTATCAATTTTATGACTGCTTGAAGA
TTGAGTGCATTTTTCCCTTGGTGCACATACAGTCGCTCTTAGTCATCCCATCCATTCTCTCTGATTCTAATATTA
TTGAATTTCCTCAGCGACTTTATTAGATGAGCATTCTATGACCATATAGTTAGGTCTAGACATTCTGATTCCTAG
TCAGGTAGACTGGACACCTATGAATATGTGATCATTCATAAGTGTCCAGTCTACCTGATTACCGCTAAGGTGCCC
TCCTGACCCAACCCATCCCTCTCTTTCTCTCTCCCTCCTTCAG
EXON 2 GAC TCG TAC AGG AAG CAG GTG GTG ATT GAT GGG GAG ACA TGT CTG CTGGAC ATC CTG
GAC ACT GCA GGT CAG GAG GAG TAC AGC GCC ATG AGG GAC CAA TACATG AGG ACA GGG
GAG GGC TTC CTC (End of insert)
Figure 10.Sequence of the 800 by PCR product insert of RT-8.72
probing a southern transfer of restricted trout genomic
DNA with the insert of RT-8.Previous attempts to
identify trout ras genes on southern transfers using
mammalian ras probes were unsuccessful.Trout genomic
DNA was digested with 9 different enzymes, electro-
phoresed through a 0.8% agarose gel, transferred to
Zeta-Probe membrane, and probed with 32P-labeled RT-8
insert as described above with the RT-8 insert (Figure
11).Distinct bands were observed in many of the
lanes.In general, the data obtained from the transfer
corroborated the restriction map information.Discrep-
ancies, such as the multiple bands in the lane
containing the Hind III digested DNA, were attributed
to incomplete digestion of the trout genomic DNA.
PCR of Trout Liver cDNA
Based on the unique trout sequence obtained from
the clone RT-8, nondegenerate primers were synthesized
for amplification of cDNA to determine whether this
trout ras gene is expressed in liver cells.Amplifica-
tion of uncontaminated trout liver cDNA using internal
5' primers derived from the RT-8 insert sequence
resulted primarily in specific PCR products that probed
positively with the RT-8 insert (Figure 12).A 215 by
trout liver cDNA PCR product (from a reaction using
RTrasHl2gly and RTrasHc81 as primers) and a 130 by
trout liver cDNA PCR product (from a reaction using
RTrasH38 and RTrasHc81as primers) were cloned as(a)
imm row.GNP
11
1-1 cNice)tr).oN.co r-1
Lane 1 - Bam HI
2 - Bam HI/Bgl II
3Eco RI
4 - Hind III
5 - Kpn I
6 - Nci I
(b)
.c) N-cooc,-t
r-I
Lane 7 - Pst I
8 - Pvu II
9 - Pvu II
10 - Xba I
11 - Xho I
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Figure 11.Southern transfer of trout genomic DNA
probed with RT-8 insert.(a) Ethidium bromide-
stained 0.8% agarose gel of trout genomicDNA
digested with several restrictionenzymes. (b)
Autoradiograph of the southern transfer probedwith
the insert of RT-8.
(Marker - 23 kb; 9 kb; 6 kb; 2.3 kb; 2.0kb; 0.5 kb)74
previously described.The inserts of several recom-
binant clones were sequenced, and 3 of the 4 clones
obtained from the reaction utilizing RTrasHl2gly as the
5' primer had sequences identical to RT-8.The fourth
clone, along with a clone obtained from the reaction
containing RTrasH38, had 3 base differences from the
RT-8 insert sequence.
After obtaining sequence information on the 5' end
of a ras gene expressed in trout liver, a modification
of the PCR technique which utilizes one specific primer
and one nonspecific primer could be used to amplify the
3' end of that gene (Ohara et al., 1989).Using
oligo(dT)15 as the nonspecific primer withany of the
specific 5' primers was not effective (data not shown),
possibly due to insufficient hydrogen bonding between
15 dA:dT pairs.A single amplification of trout liver
cDNA using poly(dT)24 as the nonspecific primer with
any of the trout specific 5' primers resulted in the
production of a variety of product sizes; however,no
probe-positive areas were visualized.In contrast, a
second amplification of the first PCR products usingan
internal 5' primer plus poly(dT)24 did result intwo
bands that probed positively with RT-8 (Figure13).
The corresponding area of a reaction amplified first
using RTrasH31 and subsequently withRTrasH38 was
isolated and cloned as above.Recombinant clones were
screened by slot blot hybridization with theRT-8 insert75
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Figure 12.PCR products of trout liver cDNA.(a) An
ethidium bromide-stained 4% acrylamide gel of
products of an amplification of uncontaminated trout
liver cDNA with trout-specific primers.(b) Auto-
radiograph of the southern transfer probed with the
RT-8 insert.Lane 7 contains the 215 by product from
a PCR amplification of trout liver cDNA using
RTrasHl2gly and RTrasc8l primers.Lane 8 contains the
131 by product from a PCR amplification of trout
liver cDNA using RTras38 and RTrasc81 primers.76
(Figure 14).The sequence of one probe-positive clone
(RT31/38-dT-8) matched the sequence of the two cDNA PCR
product clones that differed from RT-8, and none of the
differences caused a change in the amino acid sequence.
In the region extending beyond codon 81, the sequence
continued to resemble a ras gene through nucleotide 500
where it suddenly had a poly(dA) region, resulting in
an unexpectedly short product.The coding region of
the ras genes extends at least 567 bps, with additional
3' noncoding information included in the mRNA
transcript before the poly(dA) tail. Analysis of this
region in other vertebrate ras genes revealedan
abundance of adenine bases in many of the sequences,
indicating a possible annealing site for the poly(dT)24
primer that could result in the truncated PCRproduct.
Of the probe-positive clones analyzed,none contained
an insert of a size equal to the larger (possibly
nontruncated) probe-positive band identifiedon the
southern transfer.Also, no clones were identified
that matched exactly the sequence of RT-8, raising the
possibility of severalras genes being expressed in
trout liver.
In an attempt to isolate the 5' sequence of the
trout ras gene that is linked to the sequence of
RT31/38-dT-8, several different primer combinations
were used in PCR amplifications of trout liver cDNA.77
Figure 13.PCR products of the 3' end of troutras
cDNA.(a) An ethidium bromide-stained 4% acrylamide
gel of products of an amplification of trout liver
cDNA with trout-specific primers and poly(dT)24. (b)
Autoradiograph of the southern transfer probed with
the RT-8 insert.Lane 2 contains 2 probe-positive
PCR product bands of a reamplification using the
poly(dT)24 primer with RTras38 afteran original
amplification using poly(dT)24 primer withRTras31.a)
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Figure 14.Autoradiograph of a slot blot of putative
recombinant clones containing productsfrom the PCR
reamplification using the RTras38 andpoly(dT)24
primers.Clones #8 and #12 probed positively with
the RT-8 insert.80
Primers derived from the first exon of rat Ki-ras gene
sequence have recently been used in a PCR to obtain
possible Ki-ras sequence information from winter
flounder (McMahon et al., unpublished data).Amplifi-
cation of trout liver cDNA using either the RTrasH01 or
the ratKras01 as the 5' primer and either rasc79 or
RTrasHc81 as the 3' primer resulted in the expected PCR
products of 237 bps or 242 bps, respectively, which
probed positively with the RT-8 insert (Figure 15).
The PCR products were cloned as previously described,
and several clones were sequenced.Two clones
containing a PCR product from a reaction using the
ratKras01 and rasc79 have a unique ras sequence not
previously described.A clone containing a PCR product
from a reaction using RTrasH01 and rasc79 has a
sequence that is similar to both RT-6 and RT-8, but has
the same base substitutions found in RT31/38-dT-8.
Table 5 displays the insert sequences of the different
trout PCR recombinant clones.81
Figure 15.PCR products of trout liver cDNA.a)
Ethidium bromide-stained 4% acrylamide gel containing
products from PCR amplifications of trout livercDNA.
Lanes 2 through 8 contain PCR products with specific
5' primers and poly(dT)24.Lanes 10 through 13
contain PCR products with specific 5' and 3' primers.
b) Autoradiograph of southern transfer probed with
the RT-8 insert.The intense probe-positive bands
are 237 bps (Lanes 10 & 12) or 242 bps (Lanes 11 &
13).Sequences of several clonal inserts are listed
in Table 5.a)
b)
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82Table 5.Trout ras PCR product sequences.
EXON 1
10 20 30 40 50 60
Human HATGACGGAATATAAGCTGGTGGTGGTGGGCGCCGGCGGTGTGGGCAAGAGTGCGCTGACC
RT-6 T GA -A C C---
RT-8 T GA -A C C---
H01c81-4 GA -A C C---
K01c79-1 T -G A- TT TT -A TG CT A -T
Human K T A- -T ATAT -TCA CT -G
Goldfish A T CAGT -AC TC -C
Human N T -GCA TAA -T T -GACA A
70 80 90 100 110
Human HATCCAGCTGATCCAGAACCATTTTGTGGACGAATACGACCCCACTATAGAG
RT-6 C TC T T C--C---
RT-8 CT C T T C--C---
H01c81-4 C TC T T C--C---
K01c79-1 C TC T T C--C---
Human K --A AT T TTA -A
Goldfish A -C C A -C
Human N A C AT T---T CTable 5.Trout ras PCR product sequences (cont.).
EXON 2
120 130 140 150 160 170 180
Human HGATTCCTACCGGAAGCAGGTGGTCATTGATGGGGAGACGTGCCTGTTGGACATCCTGGATACCGCCGGC
RT-6 CGA A G A -TCC CT -AT
RT-8 CGA G A -T C CT -AT
HO1c81-4 CAA G C T - -C CT -AT
38dT-8 CGA G C T - - -C CT -AT
38dT-12 CGA G CA T - - -C CA -AT
KO1c79-1 CGA C - -A T - - -C CA -AT
Human K A A A- CT- C T -TC -CA -AT
Goldfish- -C T T -CT -AT
Human N TA- CTT A A -TA
Human H
RT-6
RT-8
HO1c81-4
38dT-8
38dT-12 - -A
K01c79 -1- -A
Human K - -A
Goldfish
Human N
G
AA -A
A
TA AA -A TA
190 200 210 220 230 240
CAGGAGGAGTACAGCGCCATGCGGGACCAGTACATGCGCACCGGGGAGGGCTTCCTGTGT
A A A GA C (End of insert)
A A A GA C (End of insert)
Human H
HO1c81-4
38dT-8
38dT-12
Human K
Goldfish
Human N
AA
A
A
AA
AA
T -AA
A
T A-A
A GA
A GA
A GA A
A GA A (End of insert)
A GT T -T - --
A-G--A--A
A A GA- CA
250 260 270 280 290
GTGTTTGCCATCAACAACACCAAGTCTTTTGAGGACATCCACCAGTACAGG
-- (End of insert)
-C
-A
-C - -C
-A
C
CC
T C
ATT- T -AA
T C
T - -T -G
CT- A
G-T -T
ATT TT- A
T C A
A C TTA-TCTable 5.Trout ras PCR product sequences (cont.).
EXON 3
Human H
38dT-8
38dT-12
Human K
Goldfish
Human N
Human H
38dT-8
38dT-12
Human K
Goldfish
Human N
Human H
38dT-8
38dT-12
Human K
Goldfish
Human N
300 310 320 330 340
GAGCAGATCAAACGGGTGAAGGACTCGGATGACGTGCCCATGGTGCTGGTGGGG
G A A A
- -A CA-A G ACAG--TT-ACATG-G-AGCTCAAT---GATTT AAT AAT TA -TAT C -AA A
A A A G C C
TGAAA TAT A A
350 360 370 380 390
AACAAGTGTGACCTGGCTGCACGCACTGTGGAATCTCGGCAGGCT
C-GT CGG CA CAAA
TTTTTTG-CA-AAGA----AT-TG-T--GTC--AAGACCAGTAG-
TATT C-TTAAACA AAAA
- -T TTC-GT C-G CA CAA
TTC-AA--A-G--A--T--TA-AAAA--A--C
400 410 420 430 440 450
CAGGACCTCGCCCGAAGCTACGGCATCCCCTACATCGAGACCTCGGCCAAGACCCGGCAG
T GGC-CGT T AA-A---
G----AAATAT-A---TTC-G-CTGC-TGTGTG-A-ACGG---TATA-TGTTG--ATTTC TAAA TTATTTTTA-AA -A AA -A - --
TT-A--A--G TT - -A A -A GA-A---
--C--A--G---AAGT GTA T-TA A A-A---Table 5.Trout ras PCR product sequences (cont.).
EXON 4
Human H
38dT-8
38dT-12
Human Ka
Human Kb
Goldfish
Human N
Human H
38dT-8
38dT-12
Human Ka
Human Kb
Goldfish
Human N
Mouse N
460 470 480 490 500 510
GGAGTGGAGGATGCCTTCTACACGTTGGTGCGTGAGATCCGGCAGCACAAGCTGCGGAAG
T -CT AT A -A G - -A AA -A GAGAA--T-
TATAGGATCATGTCCATTATTAGGCTAGCTTTCAGTTCTAGCTTGAGGTCATTAAAGGAA
A TTTA A A A- -AT GAT -- AAA - -A
G T -TT TA -ATA- ATAA AT- AGAAAAG-T-
A A A TTTC----A--G--A---A----AT--CG----A-A--A
T -TA TT AC----AA-A--A--A--C---T--CGAA--AAA--A
520 530 540 550 560 570
CTGAACCCTCCTGATGAGAGTGGCCCCGGCTGCATGAGCTGCAAGTGTGTGCTCTCCTGA
GCA-GGAGG-AAAAAAAAA
AGTGTGCACATGAAAAAAAAAA
A-C-G-AAAGAA--AA---C-CCTGGCT-TGTG-AA-TTAAA--A--CA-TA-AATG-A-
AGC--AGA-GG-A-AA---AGAAAAAGAAG-CA-A-...ACA AA TATG-A-
- -C-GTAAAGAA--A----CAACA-AAT--AT--A-CTT (End of insert)
--C---AGCAG TG-GACT-AGTT-G A TGCCA G GATG-A-
- -C---AGCAG---C--TG-CACT-AA--T--T---G-G-CGCCC GATG-AG87
DISCUSSION
The Polymerase Chain Reaction
PCR is a very powerful and potentially dangerous
tool.The system has the capability of amplifying two
copies of a gene from a single cell into a million
copies in only a few hours.The very real danger of
amplifying a stray molecule from an unknown source has
been documented (Kwok & Higuchi, 1989; Schochetman et
al., 1988), and extreme precautions must be taken to
avoid any carryover of DNA molecules from extraneous
sources into the PCR environment.Previously amplified
sequences and plasmid DNA are excellent substrates for
the reaction, and preparation of the reactions should
be executed in areas completely separate from the
actual reaction and analysis areas.In this study, the
first "trout" sequence obtained was identical toan
activated human Ki-ras cDNA sequence contained ina
plasmid used as a probe and as a positive control for
the PCR system.Subsequent experiments showed the
expected nonactivated sequence from human placental
DNA, but the activated human Ki-ras sequencewas
obtained from amplifications of normal rat liverDNA
and DNA isolated from 4 trout livers.The use of a
separate laboratory and positive displacement pipets
for the preparation of the reactions before amplifi-
cation, isolating the PCR products from other
reactions, and limiting the use of reamplificationwere88
some of the precautions employed to eliminate carryover
in the PCR.
Trout-Mammalian ras Homology
The first isolation of a PCR product of trout
origin was the 800 by PCR product amplified from
genomic DNA.This PCR product was cloned and
sequenced, revealing exon sequences that were highly
homologous, but not identical, to vertebrate ras genes
(Table 5).The sequencing also showed an intron of
550 bps, a size that differed from any reported verte-
brate ras gene.These differences supported the con-
clusion that the sequence was of trout origin and not
carryover of any type.Although a 90 by ras sequence
from winter flounder is reported to be identical to rat
Ki-ras (McMahon, unpublished data), the DNA sequence
homology of the 800 by PCR product identified in this
study (excluding primer regions) is 91% when compared
with reported mammalian Ha-ras sequences, and has
slightly less homology with otherras sequences (Table
6).The homology of RT-8 with human Ha-ras is 86%,
and increases to 91% only after grouping all mammalian
Ha-ras sequences together.Although base differences
are present, the differences do not cause amino acid
changes for the first 80 residues; therefore, this
sequence could code for a portion of a functional trout
ras gene.Three short stretches in the introns of
both RT-8 and human Haras have greater than 70%89
Table 6.Homology of trout ras PCR products to other
vertebrate ras gene sequences.
RT-8 H01c81:31/38dT
Human H 86% 85%
Mammalian H 91% 89%
Human K 80% 80%
Mammalian K 83% 81%
Human N 80% 82%
Mammalian N 85% 86%
Goldfish 90% 86%
homology, but very little is known about possible
significance of these sequences.Although the sequence
is closer to that of vertebrate Ha-ras genes than to
Ki-ras or N-ras, classification of this trout sequence
as one of the three classicalrasgenes would be
inappropriate based on the limited sequence information
available.
After identifying a ras gene sequence of trout
origin, additional information about the entire gene
and other related ras genes in trout can be obtained.
Southern transfers of restriction enzyme-digested trout
genomic DNA probed with human ras probes did not
reveal any probe positive bands due to insufficient
homology between the human and trout gene sequences
(data not shown).Probing similar transfers with the90
RT-8 insert, however, revealed distinct bands corres-
ponding to restriction fragments containing the
isolated trout ras sequence.For example, a single
band (approximately 6 kb) is probe-positive in a BamHI
digest of trout genomic DNA, while two bands (2 kb and
4 kb) are identified in an XbaI digest of the same DNA.
The concordance of the southern transfer probing and
the RT-8 restriction map shows the specificity of the
RT-8 insert as a probe.Although some of the larger
probe-positive restriction fragments may contain the
entire trout ras gene, this possibility has not been
confirmed.
Expression and Multiplicity of Trout ras Genes
PCR products from amplifying trout liver cDNA were
cloned, sequenced, and found to have an identical
sequence to RT-8 (except for being intronless).The
ras gene represented by the RT-8 insert is actively
expressed, and therefore a proto-oncogene and not a
pseudogene.The PCR products were made using the trout
specific 5' primers RTrasHl2gly or RTrasH38 and the 3'
primer RTrasHc81.Although three separate clones
identified contained the exact sequence of the RT-8
exons, several clones contained inserts with 2-3 base
substitutions.The base substitutions were in the
third position of specific codon triplets, andnone
resulted in amino acid changes after translation.The
Taq DNA polymerase is known to have a higher degree of91
error than other DNA polymerases (Saiki et al., 1988;
Dunning et al., 1988); however, the consistency of the
differences at positions which do not affect the amino
acid sequence suggested the presence of severalras
genes instead of the random positioning attributed to
polymerase mistakes.The expression of more than one
ras gene has been documented in several mammalian
tissues, including liver (Leon et al., 1987).Trout,
in particular, may have several very closely related
ras genes, due to a relatively recent tetraploid event
during evolution.During the tetraploid event, the
chromosomal content per cell was doubled.Although
several chromosomes have since fused, many duplicate
genes remain, upon which selection and genetic drift
can act.It is conceivable that several nearly
identical ras genes exist in the trout genome andare
expressed at some level in liver cells.
Strategies for Obtaining a Completeras cDNA Sequence
The experiments described so far used a pair of
specific primers to amplify a highly conserved region
of one or more trout ras genes.The same approach
would be less successful if applied to the 3' coding
region due to greater divergence between the different
ras genes and between species.However, using a primer
derived from the known trout sequence at the 5' end and
poly(dT)24 to anneal to the poly(dA) tail of cDNA, the
entire ras cDNA sequence from the 5' primer through the92
poly(dA) tail can theoretically be amplified using a
one-sided PCR technique (Ohara et al., 1989).This
technique employs one specific primer (in this case,
the 5' trout ras primer) and one nonspecific primer
(the poly(dT)24 primer).Since the poly(dT) primer
will anneal to the poly(dA) tail of every cDNA
transcript, the specificity of this reaction is less
than reactions using two specific primers, or than
reactions using degenerative primers for a specific
sequence.To improve the specificity of the end
product, a specific 5' primer slightly internal of the
one employed in the first amplification was used along
with the poly(dT)24 primer in a second amplification of
the first PCR products.The smaller of the two probe-
positive bands visualized on a transfer of the PCR
products is approximately 550 bps, the minimum size
expected a priori for this reaction.The larger band is
approximately 750 bps and is also a PCR product
possibly containing the 3' region of a troutrasgene.
Possible recombinant clones were screened by slot blot
hybridization using the RT-8 insert as the probe, and
two probe-positive clones were sequenced.Both
contained ras-like sequences for the region
corresponding to the second exon; however, neither
contained the exact sequence of RT-6 or RT-8 in this
region.Three to six base differences were identified
in the 85 by sequence in common between the trout93
genomic PCR clones and the RT31/38dT clones.All of
the differences occurred in the third position of codon
triplets without changing the amino acid sequence.The
clone with only three differences (RT31/38dT-8) did
match the insert sequence of several recombinant clones
that contained the PCR product from a PCR amplification
using RTrasHl2gly and RTrasHc81 as specific primers.
The clone RT31/38dT-12 diverged significantly from
vertebrate ras sequences in the region corresponding to
the third exon, and could be the result of a rearrange-
ment after the PCR amplification.Clone RT31/38dT-8,
on the other hand, agrees with the vertebrate ras
sequences midway through the fourth exon, where a
poly(dA) region occurred prematurely.Analysis of
other vertebrate ras genes in the area of the premature
poly(dA) reveals an adenine-rich region in several
sequences; for example, mouse Ki-ras exon 4b has a
stretch of 18 adenine bases out of a total of 25,
beginning with 7 adenines in a row.At the low
annealing temperatures used in the PCR procedure, this
sequence could be an alternate priming site for
poly(dT)24, resulting in the smaller PCR product.The
larger probe-positive band was not found in any of the
isolated recombinant clones.
To clarify the sequence immediately 5' to the
insert of clone RT31/38dT-8, additional PCR amplifi-
cations of trout liver cDNA were executed utilizing94
several combinations of the available primers,
including RTrasH01 and ratKras01.Using two distinctly
different primers corresponding to the first 20 bases
of several ras genes in the PCR procedure resulted in
at least two discrete products from trout liver cDNA.
In comparison, primers derived from the RT-8 sequence
resulted in the amplification of several different
trout ras sequences, although a single primer pair was
used in each reaction.The selection of the sequences
used for the PCR amplifications had a dramatic effect
on the nature of the product(s).RTrasHl2gly,
RTrasH31, and RTrasH38 were synthesized based on the
sequence of the RT-8 insert, but their use in PCR
amplifications resulted in several products in addition
to the desired sequence.The selected sequences were,
in many cases, in highly conserved regions of the
different ras genes.The first 20 bases are
distinctive between the differentras genes, and their
use defined the resultant PCR product.
The sequence of PCR products from amplifications
using ratKras01 as the 5' primer was distinct fromany
previously reported trout ras PCR product with the
exception of the 85 by overlap with the clone
RT31/38dT-12, which matched exactly.PCR products from
amplifications using RTrasH01 as the 5' primeragreed
exactly with the sequence of the 85 by overlap with
clone RT31/38dT-8.By linking the sequence of the95
clone RTrasH01c81-4 with that of the clone RT31/38dT-8,
525 bps out of a theoretical 570 bps have been
identified for one trout ras gene, and 300 bps out of
the 570 bps of a second trout ras gene can be
extrapolated from linking the clone ratKras0lc79-1 with
the first 190 bps of the clone RT31/38dT-12 (Figure
16).RT-6 and RT-8 may be allelic forms of the first
trout ras gene, or could represent entirely different
genes.Further studies are required to distinguish
between the two possibilities.
ras Genes and Carcinogenesis in Trout
The only fish species that has a published ras
gene sequence is the goldfish (Nemoto et al., 1986;
1987).A 90 by ras sequence from a PCR amplification
of winter flounder DNA has been described (McMahon,
unpublished data), with the flounder sequence being
identical to the rat Ki-ras gene.Based on the results
presented in this study and the feasibility of
carryover contamination in the PCR procedure, identical
sequences obtained from such diverse species as rat and
winter flounder should be verified independently before
publication.
The characterization of ras genes from rainbow
trout establishes a foundation for many additional
studies on the molecular biology of chemical carcino-
genesis in this model system.It is now possible toExon1 Exon 2 Exon 3 Exon 4
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Figure 16.Alignment of the trout PCRproducts.97
study the ras gene sequences in various carcinogen-
initiated tumor tissues to determine if point mutations
may be involved in trout neoplasia.The expression of
the ras genes may be quantified in northern transfers
of mRNA isolated from both normal and neoplastic
tissues.In vitro mutagenesis studies could be
employed to determine the distribution of carcinogen
adducts along a trout ras sequence.Introduction of
plasmids containing normal or mutated troutras genes
into cultured cells could increase knowledge of the
basic cellular events involved in neoplastic transfor-
mation.Introduction of trout ras genes, along with
other genes of interest, into transgenic animals also
could increase our knowledge of the neoplasticprocess.
The characterization of trout ras genes is only the
beginning of valuable information thatcan be obtained
on the molecular biology of trout neoplasia; many of
which are dependent on knowing thesequence of a trout
ras gene.98
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Res. Comm., 142, 932-938.APPENDIXAppendix Table I.List of trout ras PCR product recombinant clones.
Name Size Comments
RT-1 through RT-5
RT-6gen01-c79
RT-7gen01-c79 (15)
RT-8gen01-c79 (19)
RT-9gen01-c79 (14)
RT-10gen01-c79 (18)
RT-11genRat01-c30-a*,b,c,d
RT-12gen01-c79 (NB2)
RT-13gen01-c79 (NB6)
RT-20BamHI-XbaI
RT-21XbaI-EcoRI
RT-30cDNA12-c81-1,5,8
RT-31cDNA12-c81-2
RT-32cDNA38-c81-1
RT-33cDNAH01-c79 (1)
RT-34cDNAH01-c81 (4)
RT-35cDNAK01-c79 (1,2)
RT-40cDNA38-dT-8
RT-41cDNA38-dT-12
<216 by
804 by
804 by
804 by
804 by
804 by
90 by
804 by
804 by
500 by
300 by
219 by
219 by
131 by
237 by
242 by
237 by
-550 by
-550 by
Carryover Human Ki- rascDNA
Incl. 1st intron, not identical to RT-8
Incl. 1st intron, matches RT-8, rev.
Incl. 1st intron, consensus sequence
Incl. 1st intron, matches RT-8
Incl. 1st intron, matches RT-8
Different sequence from RT-8
Different sequence from RT-8 or RT-11
Different sequence from RT-8 or RT-11
Subclone of RT-6, Ist exon
Subclone of RT-6, 2nd exon
cDNA match of RT-8
does not match RT-8
does not match RT-8
differs slightly from RT-6 & RT-8
differs slightly from RT-6 & RT-8
differs from RT-33, RT-34, matches RT-11
3' of RT-33, RT-34, stops short of end
3' of RT-35, ?rearranges in 3rd exon